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Haplotype-based association studies have greatly aided researchers in their
attempts to map genes. However, current designs of haplotype-based association studies
lead to several challenges from a statistical perspective.

To reduce the number of

variants, some researchers have employed hierarchical clustering. This thesis starts by
addressing the multiple testing problem that results from applying a hierarchical
clustering procedure to haplotypes and then performing a statistical test for association at
each of the steps in the resulting hierarchy. Applying our method to a haplotype casecontrol dataset, we find a global p-value. Relative to the minimum p-value over all steps
in the hierarchy, the global p-value is markedly inflated. The second challenge involves
the inherent errors present when prediction programs are employed to assign haplotype
pairs for each individual in a haplotype-based association study. We examined the effect
of these misclassification errors on the false positive rate and power for two association
tests—the standard likelihood ratio test (LRTstd) and a likelihood ratio test that allows for
the misclassification inherent in the haplotype inference procedure (LRTae).

Our

simulations indicate that 1) for each statistic permutation methods maintain the correct
type I error; 2) specific multilocus genotypes that are misclassified as the incorrect
haplotype pair are consistently misclassified throughout each entire dataset; and 3) a
significant power gain exists for the LRTae over the LRTstd for a subset of the parameter
settings.

The LRTae showed the greatest benefit over the LRTstd when the cost of

phenotyping was very high relative to the cost of genotyping. This situation is likely to
occur in a replication study as opposed to a whole genome association study. The third
challenge addressed by this thesis involves the uncertainty regarding the exact
distribution of the likelihood ratio test (LRT) statistic for haplotype-based association
tests in which many of the haplotype frequency estimates are zero or very small. By
simulating datasets with known haplotype frequencies and comparing the empirical
distribution with various theoretical distributions, we characterized the distribution of the
LRT statistic as a χ2 distribution where the degrees of freedom are related to the number
of the haplotypes with nonzero frequency estimates. Awareness of the potential pitfalls
and the strategies to address them will increase the effectiveness of haplotype-based
association as a gene-mapping tool.
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CHAPTER 1: BACKGROUND

1.1

A historical perspective of genetic mapping
Over the past the twenty-five years, human gene mapping has developed into a

highly effective tool for localizing mutations which lead to disease. The startling rate of
advancement in molecular biology has provided the field with genetic and physical maps
of excellent quality while more efficient computational algorithms and more powerful
computing systems have permitted researchers to analyze larger datasets containing a
greater number of marker loci.
A wide variety of statistical approaches and study designs has been employed in
the effort to map human disease genes. Although the statistical methodology had been
developed (Morton 1955) and the algorithm refined (Elston and Stewart 1971) as well as
incorporated into software (Ott 1974) much earlier, linkage studies experienced new
levels of popularity and successfully mapped many disease genes starting in the 1980s
(Gusella et al. 1983; Monaco and Kunkel 1988; Kerem et al. 1989). Such studies proved
to be successful for mapping Mendelian disorders—disorders whose genetic basis
involves a single major gene.

These diseases show high penetrance (individuals

possessing one or two copies of the mutant allele at the disease locus have a high
probability of showing the disease phenotype) and tend to follow classical modes of
inheritance. Specifically, linkage analysis has been instrumental in localizing genes
responsible for cystic fibrosis (Eiberg et al. 1985; Knowlton et al. 1985; Wainwright et al.
1985; Schmiegelow et al. 1986; Kerem et al. 1989; Riordan et al. 1989), Duchenne
muscular dystrophy (Monaco and Kunkel 1988), Huntington disease (Gusella et al.
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1983), Charcot-Marie-Tooth disease (Ouvrier 1996), retinitis pigmentosa (Sullivan and
Daiger 1996), certain forms of early-onset breast cancer (Hall et al. 1990), and certain
forms of Alzheimer disease (Levy-Lahad and Bird 1996; Rademakers et al. 2005), among
other Mendelian disorders. Although linkage analysis has been shown to be an effective
tool for Mendelian disorders, the linkage results provide wide candidate regions which
require additional fine-mapping typically performed using linkage analysis (or
association studies) with a denser marker map in the region where linkage was initially
detected. As part of a fine-mapping analysis to narrow a candidate region, researchers
may reconstruct the haplotypes for the family and identify the largest section of the
haplotype shared by the affected study individuals (Seri et al. 1999; Bolino et al. 2000;
Lo Nigro et al. 2000; Paluru et al. 2003). In this context, haplotype phasing is determined
using the familial relationships and minimizing the number of recombination events.
In addition to linkage analysis, other statistical methods have greatly aided in the
mapping of human traits. Association studies (case-control studies) aim to find a genetic
variant that appears with the disease state more often than it should by chance alone.
When a new mutation arises in a population, the alleles at nearby polymorphic sites on
the mutated chromosome will be initially coupled with the mutant allele. As the mutation
is inherited by new generations, recombination events will eventually cause this coupling
effect to decay. However, a state of coupling or linkage disequilibrium (LD) may remain
detectable if the disease and marker loci are in sufficient proximity to one another so that
recombination events between the two loci are rare, and, consequently, the decay of the
coupling effect is very slow (Ott 1999). That is, a certain genetic variant may be
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associated with the disease state such that the frequency of the genetic variant is higher in
cases than in controls.
Linkage and association differ fundamentally. For linkage analysis, the specific
genetic variants (alleles) serve as a means to examine the linkage properties of the region
or estimate the amount of recombination between the marker and the disease. In contrast,
for association studies the genetic variants (alleles, genotypes, or haplotypes) themselves
are the center of the test and may be directly responsible for the disease phenotype. That
is, the reason an association is detected between a genetic variant and a disease is that the
variant itself causes the disease state (direct association) or is in high LD with a mutation
that causes the disease state (indirect association) (Ott 1999; Cordell and Clayton 2005).
The first major finding from genetic association studies occurred in the late 1960s
and early 1970s when a number of researchers detected an association between a number
of different diseases and the HLA (human leukocyte antigen) loci. Perhaps the best
known of these associations is that between ankylosing spondylitis and HLA-B27
because of the large number of studies able to replicate the finding (Brewerton et al.
1973; Schlosstein et al. 1973; Levitin et al. 1976; Brautbar et al. 1977; Contu et al. 1977).
These discoveries generated increased interest in association studies. However, because
the LD required to detect association exists over a short distance from the marker locus,
such association findings were rare until genetic maps with a higher density of markers
were developed. Since the regions over which LD can be detected do not extend as far as
linkage peaks, association studies traditionally have been utilized in human genetics in
order to fine map after an initial linkage analysis has implicated candidate genes for
follow up studies.

A major disadvantage of association studies is that they are
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susceptible to inflated false positive rates in the presence of population stratification or
admixture (Simpson 1951; Li 1955; Gorroochurn et al. 2004; Heiman et al. 2004) since
differences in allele (genetic variant) frequencies between cases and controls may only be
the result of differences in ethnicity between the case and control populations rather than
differences related to the disease state itself.
As a way to protect against this situation, other methods such as the haplotype
relative risk (HHR) test (Rubinstein et al. 1981; Falk and Rubinstein 1987; Thomson et
al. 1989), the haplotype-based haplotype relative risk (HHRR) test (Terwilliger and Ott
1992), and the Transmission Disequilibrium Test (TDT) (Spielman et al. 1993; Spielman
and Ewens 1996; Ewens and Spielman 2005) applied family-based controls rather than
population-based controls.

In particular, because of its ability to use the genetic

information from multiple affected siblings, the TDT and other family-based association
methods gained popularity and successfully aided in mapping genes for many diseases
including psoriasis (Helms et al. 2003; Helms et al. 2005) and sitosterolemia (Lee et al.
2001; Gordon et al. 2004). Although the TDT solved the problem caused by working
with admixed populations (excluding the situation involving extreme admixture
(Lazzeroni and Lange 1998)), the test requires additional sample collection and increased
costs to maintain the same power as association studies (Morton and Collins 1998). In
addition, the TDT has the undesirable property of an increased false positive rate in the
presence of genotyping error (Mitchell et al. 2003) or absence of parental genotype data
(Curtis and Sham 1995). Simulation studies have shown that genotyping errors and
missing parental genotypes interact to increase the false positive rate of the TDT (Barral
et al. 2005).
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Several factors have contributed to a rise in popularity of the case-control
association studies despite the issues related to population stratification. New methods
have been developed which can account for population structure in case-control studies
and, therefore, avoid the spurious associations between genes and disease that result from
admixed populations. These methods utilize additional genetic markers to correct for the
stratification using one of two approaches—genomic control (GC) (Devlin and Roeder
1999; Bacanu et al. 2000; Devlin et al. 2000; Devlin et al. 2001) and structured
association (SA) (Pritchard et al. 2000a; Pritchard et al. 2000b; Pritchard and Donnelly
2001; Kohler and Bickeboller 2006). The GC approach assumes that the effects of
population stratification should be equal across the entire genome. From the test results
of many polymorphisms at genomic regions unlikely to harbor a disease gene, the GC
approach estimates the amount of “overdispersion” or inflatedness present in the statistic
used to detect association. This estimate is then used to correct the test statistic in regions
under consideration for association. Simulation studies have shown that under some
circumstances GC methods may not completely eliminate the inflation in false positive
rate due to population stratification and under other circumstances may significantly
reduce power (Shmulewitz et al. 2004). In contrast to GC, the SA approach uses many
polymorphisms to classify individuals into subpopulations with high degrees of genetic
similarity. (The method proposed by Pritchard et al. allows for admixture in the sense
that individuals may be classified as possessing the genetic ancestry of several different
subpopulations.)

With subpopulations established, the next second step in the SA

approach performs a test for association that conditions on the inferred subpopulation
membership.
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Besides the development of these defenses against the dangers of population
stratification and the relative ease and cost-efficiency offered by case-control study
designs, in the late 1990s new technological resources, including sequence data from the
Human Genome Project, facilitated single nucleotide polymorphism (SNP) discovery
efforts and high-throughput SNP genotyping (Collins et al. 1998). Theoretical studies
show genome-wide association mapping to be a very powerful strategy for localizing
genes related to complex traits (Risch and Merikangas 1996; Risch 2000). This potential
for genome-wide association using SNP markers has prompted companies, such as
Affymetrix Inc. and Illumina, Inc., to develop as well as manufacture gene arrays and
platforms with the ability to provide genotypes for thousands of SNPs. In addition, the
work of the International HAPMAP Project, an organization dedicated to describing the
patterns of human genetic variation by developing a map of the linkage disequilibrium in
the human genome, provides a valuable resource for efficient SNP selection for custom
chip studies (International HapMap Consortium 2003; International HapMap Consortium
2005). Furthermore, large-scale genome-wide association studies have already proven
successful for identifying genes related to age-related macular degeneration and obesity
(Klein et al. 2005; Herbert et al. 2006). A final reason researchers are attracted to the
case-control design is the plausibility that in the future large databases containing
genome-wide information for controls will facilitate highly efficient case-control studies.
As described briefly above, genetic association tests aim to detect an association
between a genetic variant and the disease state. Although traditionally the genetic variant
under investigation has been an allele (Botstein and Risch 2003), a genotype, a single
haplotype, or even a diplotype (haplotype pair) can be the focus of a case-control genetic
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association test. The alleles present at multiple genetic markers inherited from the same
parent form a haplotype (Ott 1999). Often haplotypes are comprised of alleles on the
same chromosome (Brumfield et al. 2003).

Each of the forms (allelic, genotypic,

haplotypic, and diplotypic) of association testing may have advantages under specific
circumstances. For instance, test statistics that utilize single allele frequencies (or single
haplotype frequencies) may not be valid when the genotype frequencies (or diplotype
frequencies) deviate from Hardy Weinberg Equilibrium (HWE) (Sasieni 1997).
However, allelic (or haplotypic) tests of association generally are more powerful than
their genotypic (or diplotypic) counterparts because these tests have fewer degrees of
freedom (Agresti 1996).
With the advent of the HAPMAP project (International HapMap Consortium
2003; International HapMap Consortium 2005), the popularity of a relatively recently
developed form of genetic association analysis, haplotype-based case-control genetic
association studies, has grown markedly. It has been suggested that association studies
utilizing haplotypes formed from SNPs may be more powerful than single locus
association (Martin et al. 2000; Akey et al. 2001; Fallin et al. 2001; Morris and Kaplan
2002; Zaykin et al. 2002; Botstein and Risch 2003; Clark 2004; Clayton et al. 2004; De
La Vega et al. 2005; Ellis et al. 2005) . One reason haplotypes may provide a power
advantage over single SNPs in association studies is that the combined effects of multiple
sequence variants on promoter activity or protein structure (and/or function) may
precipitate the disease phenotype (Devlin and Roeder 1999; Drysdale et al. 2000; Joosten
et al. 2001). A second reason stems from a mathematical finding. It has been shown that
case-control genetic association studies are most powerful when the genetic variant under
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consideration possesses a frequency in the population identical to that of the disease
mutation (Abel and Muller-Myhsok 1998; Tu and Whittemore 1999; Pfeiffer and Gail
2003; Zondervan and Cardon 2004). Therefore, if the frequency of a single haplotypic
variant more closely matches the frequency of the disease mutation than the frequency of
any allele at any of the marker loci comprising the haplotype, a haplotype-based
association test should be more powerful than an allelic association test (Martin et al.
2000; De La Vega et al. 2005). However, haplotype-based association tests also present
some disadvantages. Techniques for directly observing haplotypes are expensive so more
often haplotypes are inferred from multilocus genotypes using statistical methods. Also,
since haplotypes generally have a large number of genetic variants compared to
genotypes or single alleles, haplotype-based association tests either possess more degrees
of freedom or face a larger multiple testing problem than tests involving a single locus.

1.2

Background for statistical tests
Regardless of the genetic variant under investigation, several approaches can be

taken to test for association. One option relies on a 2 × s contingency table, where s is
the total number of genetic variants, to record counts of the genetic information for cases
and controls. From the counts in the contingency table, a Pearson χ2 statistic, which
compares the observed counts with those expected under the assumption of independence
between case status and the genetic variant, can be computed (Pearson 1900; Agresti
1996).

An alternative approach is to calculate the likelihood ratio test (LRT) statistic,

which is twice the difference between the log-likelihood of the data under the assumption
that an association exists (between case status and genetic variant) and the log-likelihood
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of the data under the assumption that no association exists (Fisher 1922b; Fisher 1925;
Edwards 1992). When formulating the likelihood in terms of direct observations, such as
genotypes, the multinomial distribution is used.

However, when formulating the

likelihood in terms of a quantity with missing data, such as haplotypes, frequencies may
be estimated from the Expectation-Maximization (EM) algorithm (Dempster et al. 1977)
or other efficient methods and incorporated in the likelihood expression.
Both the Pearson χ2 and the likelihood ratio approaches are examples of
hypothesis testing involving two mutually exclusive hypotheses—the null hypothesis
(H0) and the alternative hypothesis (H1).

The test evaluates the data available to

determine whether sufficient evidence exists to reject the null hypothesis in favor of the
alternative hypothesis.

For genetic association tests, the null hypothesis is that no

association exists between the genetic variant and the disease state whereas the
alternative hypothesis is that such an association does exist. The general goal of a
statistical test is to maximize power while controlling for type I error. Power is the
probability of a test yielding a positive result (i.e. rejecting the null hypothesis) when in
fact the null hypothesis is false. In other words, power represents a test’s ability to find
true positives. On the other hand, type I error (or the false positive rate) represents the
probability that a test which rejects the null hypothesis will do so incorrectly. Closely
related to type I error, the statistical significance or p-value related to a test result
represents the cumulative probability of achieving an equivalent or more extreme test
result when H0 is true. Prior to a single statistical test, type I error is set to a commonly
accepted threshold (significance level) such as 0.05. A test statistic with an associated pvalue less than this threshold results in rejecting H0 in favor of H1. For example, if one
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performs 100 tests on a population for which H0 is true using the 0.05 threshold for type I
error, on average the results from five of the tests would lead to incorrectly rejecting H0.
The statistical significance, or p-value, of a test result can be evaluated in several
ways in the context of case-control association studies. However, all approaches aim to
determine the distribution of the test statistic under the null hypothesis and then use this
distribution to compute the probability of achieving a test result (when the H0 is true)
equivalent to or more extreme than the test result calculated from the data. One approach
relies on using a null distribution determined by classical statistics.

For instance,

according to statistical theory under the null hypothesis of no association both the
Pearson χ2 statistic and the LRT statistic follow a central χ2 distribution asymptotically
for large sample sizes (Agresti 1996). The number of degrees of freedom associated with
the central χ2 distribution equals one less than the number of genetic variants present in
the sample for the Pearson χ2 test and equals the difference between the number of free
parameters estimated under H1 and H0 for the likelihood ratio test. It has been shown that
when Cochran’s rule is followed (more than five observations in each cell of the
contingency table), this approach is reliable (Cochran 1952).

A second approach

employs permutation testing to generate the distribution of the test statistic under the null
hypothesis and to determine its statistical significance (Fisher 1935; Pitman 1937; Pitman
1938). In permutation testing, many null replicates of the original dataset are created by
randomly reassigning case-control labels to the individuals in the study. Then the test
statistic is computed for each replicate dataset, and the distribution of these test statistics
represents the distribution of the test statistic under the null hypothesis. While this
empirical approach provides extremely accurate p-values when a very large number of
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permutations is used (regardless of the sample size), it is computationally intensive. A
third approach is Fisher’s exact test (Fisher 1922a) which employs the hypergeometric
distribution to express the probability of contingency tables equivalent to and more
extreme than the contingency table for the dataset. Like the permutation approach,
Fisher’s exact test produces accurate p-values even with extremely small sample sizes.
However, large sample sizes or datasets associated with well-balanced tables can lead to
difficulty in executing the test.
Like computing statistical significance, there are multiple ways to determine the
power of a test for genetic association. In order to compute the power of a statistical test,
one must know the distribution of the test statistic when the alternative hypothesis is true.
In addition, the alternative hypothesis must be formulated in terms of parameters such
that the power associated with given parameter values can be established. Once the
distribution is determined, one can compute the probability that a test statistic computed
under H1 will be equivalent to or exceed the value of the test statistic associated with the
type I error threshold. One approach to finding this distribution relies on classical
statistics. For instance, according to statistical theory under the alternative hypothesis of
association, both the Pearson χ2 statistic and the LRT statistic follow a noncentral χ2
distribution asymptotically for large sample sizes (Mitra 1958; Hogg and Craig 1995;
Agresti 1996). This distribution is defined by two parameters—the degrees of freedom
(df) and the noncentrality parameter (ncp).

While the degrees of freedom can be

computed as described above in the discussion regarding statistical significance, the
noncentrality parameter can be computed as a function of frequencies belonging to the
genetic variants under investigation (in cases and controls separately), the number of
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cases, and the number of controls (see http://linkage.rockefeller.edu/derek/pawe2.html)
(Mitra 1958; Sham 1998; Gordon et al. 2002). Once parameters defining the noncentral
χ2 distribution are known explicitly, the power for a given significance level can be
determined analytically. Another approach for finding the distribution of the test statistic
under the alternative hypothesis requires data simulation. In this empirical approach,
power is computed by generating thousands of datasets under a model where there is an
association and finding the proportion of simulated datasets that produce a test statistic
equivalent to or more extreme than the value of the test statistic associated with the type I
error threshold. For a very large number of generated datasets, simulation methods
provide accurate power estimates; however, the cost of this accuracy is increased
computational time.

1.3

Multiple Testing
Recall the example describing type I error in which 100 tests were performed on a

population for which the null hypothesis is true using the 0.05 threshold for type I error.
On average, the results from five of the tests would lead to incorrectly rejecting the null
hypothesis. A somewhat analogous situation arises when it is desirable to perform a
family of tests on the same dataset.

This analogous situation complicates the

interpretation of type I error. When many tests are performed on the same dataset, each
additional test provides another opportunity for a spurious positive result. Consequently,
the probability of at least one of the tests yielding a false positive result is higher than the
type I error threshold employed for each individual test.

To protect against this

phenomenon, classical comparison procedures strive to control the family-wise error rate
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(FWER) or the probability of incorrectly rejecting any null hypothesis in a group of tests
under simultaneous consideration.
Several statistical methods have been developed to control the FWER. These
methods can be classified as single-step methods and stepwise methods (Westfall and
Young 1993). For single-step methods, such as the Bonferroni correction and the Šidák
method (Šidák 1967), equivalent multiplicity adjustments are applied to the p-values for
all tests, regardless of the ordering of the observed p-values. Since the Bonferroni and
Šidák methods assume that the tests are independent of one another, they can be
conservative when this assumption is false. In contrast, stepwise methods, such as stepup and step-down procedures, permit different adjustments for different tests depending
on the ordering of the observed p-values (Westfall and Young 1993). In recent years,
improved computing technology has facilitated the use of resampling methods, such as
bootstrapping, Monte Carlo simulations, and permutation resampling.

Specifically,

Westfall and Young have contributed several resampling methods for multiple testing
(Westfall and Young 1993). While these methods are attractive in that they often can
effectively capture the correlation structure of the tests and allow for increased power,
they may be computationally expensive.
More recently, procedures have been developed which control the false discovery
rate (FDR) rather than the FWER (Benjamini and Hochberg 1995). Such procedures aim
to ensure that on average the proportion of false positives among all positive results is
within an acceptable limit. Only for cases where the number of true null hypotheses
equals the total number of hypotheses examined are the FDR and the FWER criteria
equivalent. Otherwise, as more null hypotheses are false, the FDR becomes smaller.

13

Thus, procedures that control the FDR often have greater power than classical multiple
comparison procedures aimed at controlling the FWER (Benjamini and Hochberg 1995).
These procedures seem promising and may prove to offer an advantage over the current
practices.
In the search for susceptibility genes for human disease, multiple testing has
posed a formidable obstacle. Over the last two decades, the discovery of new varieties of
polymorphic genetic markers has aided the effort to localize disease genes.

With

Restriction Fragment Polymorphisms (RFLPs), Variable Number of Tandem Repeat
(VNTR) markers, microsatellite markers, and SNPs, researchers have millions of markers
at their disposal and continue to discover more (Sachidanandam et al. 2001; Venter et al.
2001). As a result, researchers perform tests of linkage and association for large numbers
of haplotypes, alleles, or genotypes at regular intervals across entire chromosomes or
genomes (Risch and Merikangas 1996).

Although this comprehensive approach

improves the likelihood of testing in an area of the genome where true linkage or linkage
disequilibrium (LD) exists, it requires a multiplicity of testing—one test (or more) at each
marker.

To control the false positive rate, appropriate genome-wide LOD score

thresholds have been created for tests of linkage under both homogeneity and
heterogeneity (Morton 1955; Terwilliger and Ott 1994; Lander and Kruglyak 1995;
Huang and Vieland 2001). In addition, to adjust for multiple testing for other tests, such
as association tests, the Affected Sib Pair Test (ASP), and the Transmission
Disequilibrium Test (TDT), researchers apply other forms of correction to p-values
(Lander and Kruglyak 1995; Miller 1997). Over the past few years, procedures which
control the FDR have been applied to genetic mapping (Weller et al. 1998; Devlin et al.
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2003; Sabatti et al. 2003) and the analysis of differential gene expression (Storey and
Tibshirani 2001; Reiner et al. 2003; Yang et al. 2003).

In spite of the difficulties

imposed by multiple comparisons, genome-wide testing has successfully localized many
Mendelian disorders (Gusella et al. 1983; Kerem et al. 1989; Saunders et al. 1993).
However, prominent medical conditions, such as diabetes, heart disease, schizophrenia,
and bipolar disorder, appear not to follow Mendelian patterns of inheritance but rather
involve interactions with the environment and/or other genes.

In these situations,

adjusting for multiple testing severely compromises the power of the test since testing for
main effects and interactions across the genome results in an unwieldy number of
comparisons (Dupuis et al. 1995).

1.4

Hierarchical Clustering
In addition to the multiple testing issues mentioned above, other methods

employed to organize genetic marker data also introduce a multiplicity of testing.
Hierarchical (agglomerative) clustering is an information theoretical method that
sequentially merges samples based on the pair-wise similarity of a given measurement to
form common groups until all samples are contained in a single group (Hastie et al.
2001). The method has many applications and is widely used in the analysis of biological
data. For example, researchers testing for association between haplotypes and disease
have employed hierarchical clustering as a means to reduce a large number of haplotypes
to a manageable number of haplotype classes with the aim to increase statistical power
(Hoehe et al. 2000). With an increasing number of marker loci, the number of possible
haplotypes grows exponentially so that many of these haplotypes tend to have low
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frequency.

This situation is relatively common when examining haplotypes within

candidate genes because of the availability of dense SNP marker maps, in which the
spacing between markers often is less than one kilobase (Sachidanandam et al. 2001). In
comparisons of haplotype frequencies between case and control individuals, the
corresponding contingency tables are therefore often sparse and difficult to interpret.
Hierarchical clustering then allows researchers to merge haplotypes into classes that are
easier to handle.

At each step within the hierarchy, either implicitly or explicitly,

researchers tend to interpret results and eventually focus on that set of classes providing
the most significant result. Testing at each of the different clustering steps within a
hierarchical structure also represents a form of multiple comparisons; therefore, the
minimum p-value evaluated over many steps is too small to represent the experimentwise significance level.
Many methods, including hierarchical clustering, can be applied to partition a
dataset into subgroups whose elements share common characteristics. Several methods
of non-hierarchical clustering or partitional clustering exist. Some common partitional
methods include k-means clustering (MacQueen 1967), quality threshold (QT) clustering
(Heyer et al. 1999), and fuzzy clustering (Dunn 1973).

In addition, hierarchical

clustering has two varieties—1) agglomerative (bottom-up) clustering in which the
groups are built up at each progressive stage of clustering so that each item starts in its
own group and 2) divisive (top-down) clustering in which a single group exists initially
and items are removed as clustering progresses. Once a hierarchical clustering procedure
constructs a dendrogram or tree diagram representing the grouping structure, the dataset
can be divided into any number of groups by selecting the appropriate clustering stage or
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level.

In order to construct the grouping structure, the procedures must define the

distance between groups. One option, single linkage, defines the distance between two
groups as the minimum pair-wise distance between any item in the first group and any
item in the second group whereas another option, complete linkage, finds distance as the
maximum pair-wise distance between any item in the first group and any item in the
second group. A third option, average linkage, uses the average of all pair-wise distances
between items in the two groups (Johnson 1967). In addition, there are several metrics
for determining pair-wise distance between individual items. Common distance metrics
include Euclidean distance, squared Euclidean distance, Manhattan distance, and the
correlation coefficient.

1.5

Estimation, inference, and haplotype-based association
Methods which apply techniques, such as allele-specific long-range PCR and

somatic cell hybrid construction, from molecular biology for explicit determination of
phased haplotypes are available (Papadopoulos et al. 1995; Michalatos-Beloin et al.
1996; Clark et al. 1998; Yan et al. 2000; Douglas et al. 2001; Patil et al. 2001; Burgtorf et
al. 2003; Ding and Cantor 2003; Horan et al. 2003; Hoppe et al. 2004; Proudnikov et al.
2004; Yu et al. 2004; Hoppe et al. 2006; Proudnikov et al. 2006). However, because
current molecular haplotyping methods are expensive and not amenable to automation, in
practice phased haplotypes are rarely determined explicitly. Instead, statistical methods
for gene mapping estimate haplotype frequencies from multilocus genotype data and
often provide haplotype assignments or calls for individuals (Clark 1990; Xie and Ott
1993; Terwilliger and Ott 1994; Excoffier and Slatkin 1995; Hawley and Kidd 1995;
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Long et al. 1995; Zhao et al. 2000; Stephens et al. 2001b; Zhao and Sham 2002; Stephens
and Donnelly 2003). Since the parental origins of the two alleles comprising any single
genotype are not directly observed, constructing phased haplotypes from multilocus
genotypes can be complicated. Consider two SNP marker loci where A and a represent
the alleles at the first locus while B and b represent the alleles at the second locus. One
can assign haplotype pairs unequivocally for all possible multilocus genotypes except for
the double heterozygote AaBb. For instance, the multilocus genotype AaBB, must derive
from the haplotype pair AB and aB. In contrast, the multilocus genotype AaBb either
derives from the haplotype pair AB and ab or the haplotype pair Ab and aB. Such
ambiguous cases occur for any multilocus genotype possessing two or more loci with a
heterozygote.

As with fine mapping in linkage studies, knowledge of the parental

genotypes can greatly simplify the problem of phasing.

However, for case-control

association studies, the sampling design involves unrelated individuals, and,
consequently, parental genotypes are rarely collected. Therefore, the procedure utilized
to estimate haplotype frequencies treats each individual as an independent observation.
Several methods have been developed to estimate haplotype frequencies for nonfamilial study designs. While the first method developed for haplotype estimation is
based on the principle of maximum parsimony (Clark 1990; Wang and Xu 2003),
methods that rely on the Expectation-Maximization (EM) algorithm (Dempster et al.
1977) for a likelihood approach (Xie and Ott 1993; Excoffier and Slatkin 1995; Hawley
and Kidd 1995; Long et al. 1995) or use a Bayesian approach applying a prior based on
coalescence theory (Stephens et al. 2001b; Stephens and Donnelly 2003) or a Dirichlet
prior (Niu et al. 2002) are more commonly used.
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Although it is a relatively

straightforward method, Clark’s method has several disadvantages among which are its
inability to provide unique solutions and its sensitivity to deviations from HWE (Niu et
al. 2002; Niu 2004). In contrast, the EM algorithm-based and Bayesian approaches have
been shown to be relatively robust to such deviations (in spite of the fact that the EM
algorithm-based approaches assume HWE) (Niu et al. 2002; Niu 2004). Each of these
approaches has been implemented in statistical software. Specifically, the parsimonybased methods are implemented in HAPINFERX and HAPAR (Wang and Xu 2003); the
EM algorithm-based methods are implemented in SNPHAP (see Electronic Resource
Information), HAPLO (Hawley and Kidd 1995), and PL-EM (Qin et al. 2002); and the
Bayesian approaches are implemented in PHASE (Stephens et al. 2001b) (see Electronic
Resource Information) and HAPLOTYPER (Niu et al. 2002).
As with other procedures for statistical estimation, the accuracy of haplotype
frequency estimates depends on several factors including “sample size, number of loci
studied, allele frequencies, and locus-specific allelic departures from Hardy-Weinberg
and linkage equilibrium” (Fallin and Schork 2000). Furthermore, these factors also affect
the accuracy of phased haplotype inference or phased haplotype calls (Niu 2004).
Several researchers have investigated the accuracy of haplotype inference procedures by
applying them to real and simulated data sets (Tishkoff et al. 2000; Clark et al. 2001; Xu
et al. 2002; Stephens and Donnelly 2003; Adkins 2004; Kang et al. 2004; Niu 2004; Xu
et al. 2004; Heid et al. 2005; Sabbagh and Darlu 2005; Zhang et al. 2005; Marchini et al.
2006; Proudnikov et al. 2006). In addition, Douglas et al. found molecular haplotyping
provided large efficiency advantages over haplotype inference from multilocus genotypes
under the condition of linkage equilibrium between marker loci (Douglas et al. 2001).
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Using simulation studies, Schaid extended the work of Douglas et al. to conditions with
linkage disequibrium between the markers. The studies found that the advantage of
molecular haplotyping over haplotype inference decreased with increasing LD (Schaid
2002). Similar studies have investigated the power advantage of molecular haplotyping
over haplotype estimation techniques for genetic association studies (O'Hely and Slatkin
2003; Thomas et al. 2004).
As described earlier, multiple statistical methods, such as the Pearson χ2 test and
the likelihood ratio test, are available to perform tests of case-control association.
However, since the original observations (multilocus genotypes) lack phase information,
the testing situation is a bit more complex. This additional complexity results in issues
unique to tests of haplotype-based association as compared with other genetic association
tests. In accord with the earlier description, the likelihood ratio test for haplotype-based
association involves calculating the likelihood of the data in terms of the estimated
haplotype frequencies (Xie and Ott 1993; Fallin et al. 2001). However, some haplotypic
variants may be estimated to have a small frequency despite the fact that none of the
study participants comprising the sample possess them. The effect of this situation on the
distribution of the resulting test statistic under both null and alternative hypotheses
remains unclear.

One still expects that the test statistic will follow a central χ2

distribution under H0 and a noncentral χ2 distribution under H1. However, the degrees of
freedom associated with either χ2 distribution are no longer well defined.
Also analogous to the earlier discussion, an alternative method for haplotypebased association relies on the use of a contingency table containing the case-control
counts for each inferred haplotype.

The counts in the contingency table can be
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determined either by inferring phased haplotypes for each individual or by multiplying
each haplotype frequency estimate by the total number of haplotypes in the study. With
data in the completed contingency table, either a Pearson χ2 test or a likelihood ratio test
can be performed. Many researchers find this second method with the contingency table
appealing since it applies the same format as classic genotypic and allelic case-control
studies and explicitly accounts for each phased haplotype. As a result, many researchers
employ this method in practice (Hoehe et al. 2000; Maksymowych et al. 2003; Xu et al.
2004; Hindorff et al. 2006; Proudnikov et al. 2006).

In the event that all phased

haplotypes have been called correctly, this method can provide additional power (Cox
and Hinkley 1974; Little and Rubin 1987).

This situation is analogous to tests of

association using allele estimates from individual genotypes as compared with allele
frequency estimates from DNA-pooling data (Johnson et al. 2001).
However, misclassifications can lower a study’s power and/or affect the false
positive rate. The act of calling haplotype pairs from multilocus genotypes in the phase
ambiguous situation is similar to the act of dichotomizing continuous measures. Royston
et al. document a loss in power when dichotomizing continuous predictor variables in a
regression analysis (Royston et al. 2006). In the context of a haplotype-based association
study utilizing the contingency table design, a misclassification results when the
haplotype pair called for an individual is not the true underlying haplotype pair. Nondifferential misclassification occurs when the misclassification rates are the same in cases
and controls. When non-differential misclassification exists, the test suffers a loss in
power but the false positive rate remains unchanged (Mote and Anderson 1965; Gordon
et al. 2002). In contrast, differential misclassification inflates the test’s false positive rate
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and may diminish its power (Clayton et al. 2005). In addition to errors due to the
statistical procedure, misclassification of the multilocus genotypes will lead to miscalling
haplotype pairs. In the absence of differential genotype misclassification, all haplotype
misclassification should be non-differential when haplotype frequency distributions are
the same in cases and controls, i.e. under the null hypothesis.
This thesis addresses several of the challenges currently confronting investigators
conducting haplotype-based association studies. Chapter 2 examines the multiple testing
problem that results from applying a hierarchical clustering procedure to haplotypes and
then performing a statistical test for association at each of the steps in the resulting
hierarchy. The proposed approach to overcome this challenge is creating an experimentwise statistic of interest and finding its significance.

Chapter 3 explores the

consequences of the errors present when haplotype prediction programs are employed to
assign haplotype pairs for each individual in commonly used tests of haplotype-based
association. While there have been several studies aimed at evaluating the accuracy of
haplotype inference and haplotype frequency estimation procedures (Fallin and Schork
2000; Tishkoff et al. 2000; Clark et al. 2001; Xu et al. 2002; Stephens and Donnelly
2003; Niu 2004; Xu et al. 2004; Sabbagh and Darlu 2005; Marchini et al. 2006), no
systematic study has documented the effects of haplotype misclassification on the false
positive rate and power. In this chapter, we compare the performance of a test statistic
that utilizes a double-sampling procedure to account for haplotype misclassification with
the standard likelihood ratio test statistic.

Chapter 4 investigates the uncertainty

regarding the exact distribution of the likelihood ratio statistic under the null hypothesis
of no association for haplotype-based association tests in which many of the haplotype
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frequency estimates are zero or very small.

In this chapter, we characterize the

distribution of the LRT statistic by simulating null datasets with known haplotype
frequencies and comparing the empirical distribution with various theoretical
distributions. Finally, chapter 5 draws some conclusions from these studies and discusses
future directions for research related to haplotype-based association.
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CHAPTER 2: HIERARCHICAL CLUSTERING AND GLOBAL
SIGNIFICANCE

2.1

Introduction
New techniques in the biological sciences, like high throughput genotyping,

microarray chip assays, and an explosion of online databases, have created a wealth of
information regarding biological systems. The burgeoning discipline of bioinformatics
illustrates the need for data organization and the development of statistically sound
methods for analysis. An increasingly common issue for a variety of applications in
biology is the artificial inflation of statistical significance associated with multiple
testing.
With the increasing amount of data generated in molecular genetics laboratories,
it is often difficult to make sense of results because of the vast number of different
outcomes or variables studied. Examples include haplotypes comprised of large numbers
of loci and expression levels for large numbers of genes. It is then natural to group
observations into smaller numbers of classes that allow for an easier overview and
interpretation of the data. This grouping is often carried out in multiple steps with the aid
of hierarchical cluster analysis, each step leading to a smaller number of classes by
combining similar observations or classes.
For example, researchers testing for association between haplotypes and disease
have employed hierarchical clustering to reduce a large number of haplotypes to a
manageable number of haplotype classes with the aim to increase statistical power
(Hoehe et al. 2000). With an increasing number of marker loci, the number of possible
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haplotypes grows exponentially so that many of these haplotypes tend to have low
frequency.

In comparisons of haplotype frequencies between case and control

individuals, the corresponding contingency tables are often sparse and difficult to
interpret.

Several strategies, such as pooling the rarest categories to form a single

haplotype class (Sham and Curtis 1995; Schaid et al. 2002; Zhao et al. 2003) and using
haplotype diversity criteria for SNP selection (Johnson et al. 2001; Jannot et al. 2004)
(http://www-gene.cimr.cam.ac.uk/clayton/software/stata/htSNP/htsnp.pdf),

have

been

suggested to reduce the number of classes. Unlike these alternatives, hierarchical
clustering allows researchers to merge haplotypes, based on sequence similarities, into
classes that are easier to handle. Initially, each haplotype is considered to be its own
class. With each step in the clustering process, haplotype classes are merged based on
the pair-wise similarity of the allele sequences comprising the haplotypes contained
within each class until all samples are contained in a single haplotype class. At each step
in the resulting hierarchy, either implicitly or explicitly, researchers tend to interpret
results and eventually focus on the set of classes providing the “best” (most significant)
result.

While this approach makes sense, the overall statistical significance of the

experiment must include the clustering process, which modifies the grouping structure of
the data.
Another example of hierarchical clustering is its application in microarray
analyses (Eisen et al. 1998; Alon et al. 1999; Gasch et al. 2000). Often clustering of
arrays based on microarray expression data is utilized to distinguish tumor subclasses,
which have clinical implications (Golub et al. 1999; Chung et al. 2002). In many of these
studies involving microarray expression data from tumor specimens, researchers are
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interested in examining survival information for the subjects who contributed the samples
and comparing the survival curves between groups formed by the hierarchical clustering
procedure (Alizadeh et al. 2000; Bhattacharjee et al. 2001; Garber et al. 2001; Sorlie et al.
2001; Guo et al. 2006; Perreard et al. 2006). After performing cluster analysis on the
expression data, researchers tend to concentrate their attention on the step in the resulting
hierarchy with the most striking difference in survival between patient groups and
evaluate this result without taking into account the grouping structure at the other steps.
Here we propose an analysis method that properly takes the process of clustering
into account. We achieve this by defining the strongest result or, equivalently, the
smallest p-value, occurring in the course of clustering as the statistic of interest and
computing its associated (experiment-wise) empirical significance level. The methods
developed in this chapter will be applied to three previously published datasets in which
hierarchical clustering has been employed. One of these datasets involves a haplotypebased association analysis while the other two datasets refer to survival analyses of
groups of individuals determined by microarray expression measurements.
The problem of testing group differences sequentially is in the framework of
multiple testing. Historically, both genetic association studies and microarray studies
have been plagued with multiple testing problems. In the case of association studies,
multiple testing occurs because researchers perform tests of association for large numbers
of haplotypes, alleles, or genotypes across entire chromosomes or genomes (Risch and
Merikangas 1996). In the case of microarray data analysis, researchers sequentially test
thousands of genes for differential expression. Testing at each of the different clustering
steps within a hierarchical structure also represents a form of multiple comparisons;
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therefore, the experiment-wise type I error is inflated. Various correction methods such
as Bonferroni, step-up, and step-down have been employed to adjust for the multiplicity
of testing (Reiner et al. 2003). These procedures appear to work well only when the tests
in the sequence are independent or weakly correlated.

Since the tests within the

hierarchy possess a nested structure, these procedures are inappropriate for our situation.
As mentioned above, here we propose an alternative solution by defining a single test
statistic, for which we evaluate the experiment-wise statistical significance.

2.2

Methods
Local p-values. Consider multiple steps in hierarchical clustering. For each of n

steps of the hierarchy, we calculate our statistic of interest depending on the application.
In the case of haplotype-based association tests, we compute the Pearson χ2 (Agresti
1996) for a 2 × s contingency table (case/control individuals versus s haplotypes or
haplotype classes) while, in the case of survival analyses, we compute the log-rank
statistic (Kalbfleisch and Prentice 1980).

We represent these statistics as a

r
vector, X = ( X 1 , X 2 ,..., X n ), where Xi represents the statistic obtained at the ith step in the

clustering process.

To make statistics from different applications comparable, we

compute the empirical significance level, pi, associated with Xi and call this a local pvalue.
We approximate these local empirical significance levels via permutation
analysis.

These permutation methods involve randomly permuting labels for each

individual as follows. For haplotype-based association tests, we permute the case/control
labels (Zhao et al. 2000; Zhao and Sham 2002) while for survival analyses, we permute
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failure times and censorship statuses jointly. For each permutation of the dataset, we
cluster the permuted samples as illustrated by the dendrogram and calculate a null
statistic based on the permuted samples at each step in order to generate the null
distribution for the statistic. We can represent the collection of null statistics calculated
from each of m permutations of the data at each of n steps within the hierarchy as the
matrix,

X null

 X 11
=  M
 X m 1

L
O
L

X 1n 
M 
X mn 

,

where the entry appearing in the ith row and the jth column, Xij, is the statistic of interest
computed from the ith permutation of the data at the jth step in the hierarchy. At each step
of the hierarchy, by comparing the statistic we computed from the data with the null
statistics we computed from the m permutations, we calculate a local p-value, pj, as the
proportion of permutation samples with a null statistic at least as large as the observed
statistic. That is, the local p-value, pj, is the proportion of null statistics in the jth column
of Xnull that are greater than or equal to the statistic, Xi, calculated from the data at the jth
r
step in the hierarchy. We represent the local p-values as the vector, p = ( p1 , p2 ,..., pn ).
Permutation (randomization) samples allow one to conveniently approximate the
sampling distribution of test statistics under the null hypothesis (the “null distribution”).
Ideally, permutation tests are based on the total of all permutations but in practice we
usually can only collect a random sample from these permutations. The number m of
permutation samples should be large enough to adequately represent the sample space of
permutations.

For the haplotype data (example 1), at each step we compared

approximated p-values obtained with different values of m to exact p-values calculated
28

using the statistical software package StatXact 5 (see Electronic Resource Information).
For the first few steps in the hierarchy, values of m on the order of 10,000 were sufficient
to provide p-values very close to the correct ones. However, at later steps, agreement
was only obtained with m = 100,000, presumably because at early steps the total number
of permutations is much smaller than at later steps. Table 2.1 displays the local p-values
for example 1 computed both with our method using 100,000 permutation samples and
with Pearson’s exact test as implemented in StatXact 5. The calculations for the two
survival analyses (examples 2 and 3) were also performed with m = 100,000.
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Table 2.1 Comparison of local p-values computed using our method with p-values
computed using exact tests
Step

Local p-Value

95% C.I.

Exact Test p-Value

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

0.5275
0.4736
0.4710
0.3533
0.3930
0.2844
0.2726
0.2229
0.1502
0.1282
0.1166
0.0929
0.0668
0.0425
0.0292
0.1659
0.2362
0.1486
0.1089
0.0477
0.0424

(0.5244, 0.5306)
(0.4705, 0.4767)
(0.4679, 0.4741)
(0.3503, 0.3563)
(0.3900, 0.3960)
(0.2816, 0.2872)
(0.2700, 0.2754)
(0.2203, 0.2255)
(0.1480, 0.1524)
(0.1261, 0.1303)
(0.1146, 0.1186)
(0.0911, 0.0947)
(0.0653, 0.0684)
(0.0413, 0.0438)
(0.0282, 0.0303)
(0.1636, 0.1682)
(0.2336, 0.2388)
(0.1464, 0.1508)
(0.1070, 0.1108)
(0.0464, 0.0490)
(0.0412, 0.0437)

0.5270
0.4739
0.4718
0.3532
0.3928
0.2825
0.2706
0.2205
0.1501
0.1289
0.1165
0.0929
0.0674
0.0433
0.0298
0.1659
0.2379
0.1500
0.1099
0.0482
0.0423

Legend for Table 2.1: This table displays the local p-values computed for example 1 using both
our method with 100,000 permutation samples and Pearson’s exact test as implemented in
StatXact 5. In addition, the table provides the 95% confidence interval for the p-value estimates
computed by our method. The zeroth step refers to the data before any clustering is performed.
For the test at the zeroth step, the Monte Carlo method (500,000 tables sampled) in StatXact 5
was employed to find the p-value since the problem was too large for the exact test.

Global p-value. In order to gain an empirical significance assessment for the
entire experiment, we define a single statistic, that is, the smallest of the local pvalues, min i ( pi ) (Hoh et al. 2001). To assess the empirical significance level (global p30

value), pmin, associated with this statistic we generate the null distribution
of min i ( pi ) from the matrix of null statistics, Xnull. In this matrix, we consider each row
(replicate dataset) in turn as observed data and evaluate these data based on the remaining
m – 1 null data as described above for m null data. That is, for each of these “null
observed” permutation samples a minimum p-value is obtained at whatever step it occurs.
This leads to a set of m null values for min i ( pi ) . The proportion of these values at least
as small as the observed min i ( pi ) represents the global significance level, pmin, associated
with our single experiment-wise statistic. Since this approach requires that the p-values
be ordered, starting with the most significant, it could be considered a step-down p-value
adjustment procedure similar to the procedure developed by Westfall and Young
(Westfall and Young 1993). If pmin ≤ 0.05 then we say that the experiment (at least one
of the steps in the clustering process) is significant at the 5% level.
It is also of interest to compare the global p-value with the significance level, p0,
of the association or log-rank statistic before clustering since clustering is only beneficial
when pmin < p0. It may well happen that the smallest p-value, min i ( pi ) , at one of the
steps in the course of clustering is smaller than p0 but the clustering process is such that
this smallest p-value has a high probability of occurring by chance. In that case, one will
find that pmin > p0. For example, observing a minimum p-value smaller than 0.05 and
interpreting it as significant is fallacious when this small p-value is easily obtained with
probability pmin > 0.05.

Statistics of interest. As mentioned above, in the case of association studies
between haplotypes and disease we employ the Pearson χ2 to test each step of the
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hierarchy for association (Agresti 1996). However, in the case of survival analyses, our
statistic of interest is the log-rank statistic (Kalbfleisch and Prentice 1980). It provides an
overall comparison of the Kaplan-Meier survival curves for two or more groups of
subjects.

For r groups, the log-rank statistic asymptotically follows a central χ2

distribution with r – 1 degrees of freedom under the null hypothesis of equality of
survival curves.

Validation of the algorithm. In order to validate this method, we analyzed
several datasets with a strategy nearly identical to the one described above. The only
difference was that this second strategy relies on the theoretical χ2 distribution to
determine the local p-values. Since the use of the theoretical χ2 distribution for finding
statistical significance is valid only for non-sparse datasets, we analyzed several nonsparse datasets with both procedures and compared the results.
In addition, we validated our method using an analytical approach. Suppose we
have n steps in the hierarchy formed by clustering, and a test is performed at each step.
Then under the null hypothesis, local p-values at all steps of clustering are standard
uniform random variables. We can express the global p-value as

{

Pr min i ( pi )

null

≤ min i ( p i )

obs

}

(2.1)

or the probability that value for the minimum of the local p-values from data under the
null hypothesis, min i ( pi ) null , is less than or equal to the value of the minimum of the

local p-values from the observed data, min i ( pi ) obs .

Applying a basic axiom of

probability involving complementary events (Ross 2002), we can alter expression (2.1) to
become the expression,
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{

}

1 − Pr p1 > min i ( pi ) obs , p 2 > min i ( pi ) obs , K, p n > min i ( pi ) obs .

(2.2)

Under the assumption of independence, this expression simplifies to the Bonferroni
correction. However, since the tests are correlated due to the nested structure of the
hierarchy, we must pursue an alternate approach. We would like to use the correlation
structure between steps to determine this joint probability. Although the multivariate
uniform distribution from which the null local p-values are derived does not have a one to
one correspondence between the correlation structure and the probability density function
(pdf), the multivariate normal distribution does have this property. We apply the inverse
normal cumulative density function (cdf) to transform the null local p-values from
standard uniform random variables to a multivariate normal distribution with variancecovariance matrix, V, and mean vector, u . We uniquely define the multivariate normal
distribution by setting u to be a vector composed entirely of 0 values and using the
transformed local p-values to estimate V. Thus, after the transformation of variables, we
can rewrite expression (2.2) as

{

(

)

(

)

(

)}

1 − Pr Y1 > Φ −1 min i ( pi ) obs , Y2 > Φ −1 min i ( pi ) obs ,K, Yn > Φ −1 min i ( pi ) obs ,

(2.3)

where each Yi is the transformed null local p-value at the ith step and Φ −1 is the inverse
standard normal cdf. Because of symmetry, the expression becomes

{

(

)

(

)

(

)}

1 − Pr − Y1 < −Φ −1 min i ( pi ) obs ,−Y2 < −Φ −1 min i ( pi ) obs , K ,−Yn < −Φ −1 min i ( pi ) obs .(2.4)

Since -Yi also follows a multivariate normal distribution with V and u , the quantity can
be expressed as a function of the cdf of this multivariate normal distribution as in
expression (2.5).

[

(

)

(

)

(

1 − cdf − Φ −1 min i ( pi ) obs ,−Φ −1 min i ( pi ) obs ,K,−Φ −1 min i ( pi ) obs
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)]

(2.5)

With this analytical approach, we examined two datasets—one consisting of two
steps as a result of clustering (calibration) and another consisting of nine steps as a result
of clustering (analysis). Table 2.2 and Table 2.3 display the contingency tables at each
step of clustering for the two-step and nine-step datasets, respectively. For both datasets,
we used Mathematica v.4.2 to compute the cdf in expression (2.5). In our estimate of V,
the diagonal elements were rounded to the value 1. For the two-step dataset, we found an
explicit value for the global p-value using the analytical method. For the nine-step
dataset, we were unable to analytically determine an explicit value for the global p-value
due to limitations of software. Instead, we established an upper and a lower bound by
applying the analytical approach twice—once using the minimum pair-wise covariance
estimate for all off-diagonal elements of V and a second time using the maximum pairwise estimate for all off-diagonal elements of V. Thus, the first calculation, assuming the
minimum correlation structure, provides a lower bound while the second calculation,
assuming the maximum correlation structure, provides an upper bound. We compared
the results applying the analytical approach with those from our original algorithm for
determining pmin. For the validation, we used 10,000 permutation datasets.
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Table 2.2 Contingency tables for two-step dataset used for method validation

Step
0
1

Group

Number of
Cases

Number of
Controls

Group 1
Group 2
Group 3
Group 1
Group 2

32
24
20
56
20

18
16
30
34
30

Legend for Table 2.2: This collection of contingency tables displays the case-control counts for
the haplotype classes present at each of the two steps of clustering for a dataset used to validate
the method employed to find the global p-value. The zeroth step refers to the data before any
clustering is performed.
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Table 2.3 Contingency tables for nine-step dataset used for method validation
Step

0

1

2

Group
Group 1
Group 2
Group 3
Group 4
Group 5
Group 6
Group 7
Group 8
Group 9
Group 10
Group 1
Group 2
Group 3
Group 4
Group 5
Group 6
Group 7
Group 8
Group 9
Group 1
Group 2
Group 3
Group 4
Group 5
Group 6
Group 7
Group 8

Number Number of
of Cases Controls
10
7
11
6
12
6
17
8
11
12
10
7
11
6
12
6
17
8
23
10
7
11
6
12
6
25
23

10
8
14
9
13
9
13
7
9
8
10
8
14
9
13
9
13
7
17
10
8
14
9
13
9
20
17

Step

3

4

5

6

7
8

Group
Group 1
Group 2
Group 3
Group 4
Group 5
Group 6
Group 7
Group 1
Group 2
Group 3
Group 4
Group 5
Group 6
Group 1
Group 2
Group 3
Group 4
Group 5
Group 1
Group 2
Group 3
Group 4
Group 1
Group 2
Group 3
Group 1
Group 2

Number of Number of
Cases
Controls
10
7
11
6
18
25
23
10
7
17
18
25
23
17
17
18
25
23
17
17
18
48
17
35
48
52
48

10
8
14
9
22
20
17
10
8
23
22
20
17
18
23
22
20
17
18
23
22
37
18
45
37
63
37

Legend for Table 2.3: This collection of contingency tables displays case-control counts for the
haplotype classes present at each of the nine steps of clustering for a dataset used to validate the
method employed to find the global p-value. The zeroth step refers to the data before any
clustering is performed.

2.3

Results
To demonstrate our approach on real data, we reanalyze the following three

previously published datasets.
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Example 1 (haplotype data).

The first dataset consists of 52 statistically

predicted haplotypes in 172 African-American study participants (137 case and 35
control individuals) (Hoehe et al. 2000). The aim of that case-control study was to test
for association between haplotypes at 25 single-nucleotide polymorphism (SNP) loci in
the human µ opioid receptor gene (OPRM1) and substance dependence. The large
number of haplotypes was difficult to interpret and appeared to create a situation with
insufficient power to detect association. Thus, hierarchical clustering was applied to the
52 haplotypes. These were sequentially grouped according to the procedure CLUSTER
(method = BAVERAGE, measure = SEUCLID) from the SPSS software package for
Windows (Hoehe et al. 2000). For each step of the resulting dendrogram shown by
Figure 2.1, the hierarchical clustering procedure designates which haplotypes are
clustered to form haplotype classes. At each step of the hierarchy an association test was
performed between haplotype classes and disease status. As the clustering progressed,
the number of classes became smaller and smaller.
Using the same clustering methods and resulting hierarchical structure, we apply
our algorithm for assessing local and global p-values in this dataset. Our p-values differ
somewhat from the ones previously published (Hoehe et al. 2000) but the patterns of the
local p-values across the clustering steps shown in Figure 2.2 and in the publication by
Hoehe et al. (Hoehe et al. 2000), respectively, are highly comparable.

Based on

m = 100,000 permutation samples (see section 2.2), we calculate local p-values for
hierarchical clustering steps zero through 20, where zero represents the step with unclustered haplotypes and 20 represents the step where only two haplotype groups remain.
We find the smallest p-value, min i ( pi ) = 0.0292, at step 14 (Figure 2.2). Thus, one is
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tempted to declare this result borderline significant at the 5% level. However, the
(global) significance level associated with this smallest p-value turns out to be
pmin = 0.1328, that is, there is more than a 13% random chance (unrelated to association
between haplotypes and disease) to find at any step in the hierarchy a minimum p-value
at least as small as the value of 0.0292 found for the observed data. This result leaves the
experiment statistically non-significant. Since clustering produced an experiment-wise
significance level of pmin less than the initial pre-clustering significance level of
p0 = 0.5275, the clustering process did provide a benefit for this dataset (even though the
results from clustering were not statistically significant).

Figure 2.1 Dendrogram created by clustering data from Hoehe et al. (Hoehe et al. 2000)

Legend for Figure 2.1: This schematized dendrogram reflects the process of clustering casecontrol observations based on the similarity of haplotype data as measured by the squared
Euclidean distance. Distances between haplotype classes are approximated (not to scale) by the
vertical axis. Along the bottom of the dendrogram are the identification numbers for the inferred
haplotypes as described by Hoehe et al. (Hoehe et al. 2000).
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Figure 2.2 Results from haplotype-based association tests applied to all steps of the

hierarchical structure formed by clustering data from Hoehe et al. (Hoehe et al. 2000)
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Legend for Figure 2.2: This bar graph presents the local p-values we computed at all steps with
hierarchical structure.

Example 2 (lung cancer data). This dataset contains expression levels for 835

unique genes represented by 918 cDNA clones in tissues harvested from lung cancer
patients and normal individuals (Garber et al. 2001). Specifically, expression levels are
measured in 41 adenocarcinomas (ACs), 16 squamous cell carcinomas (SCCs), five large
cell lung cancers (LCLCs), five small cell lung cancers (SCLCs), five normal lung
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samples, and one normal fetal lung sample. Based on the Complete Linkage method and
Pearson’s correlation coefficient as a measure of similarity in the CLUSTER software,
hierarchical cluster analysis was performed to group the samples according to the degree
of similarity present in the gene expression data. In the resulting dendrogram, the AC
samples appeared in three distinct clusters. The aim of the study was to examine whether
the groups of AC samples created by the hierarchical clustering procedure correlated with
clinical outcomes of the AC patients, that is, whether the Kaplan-Meier survival curves
differed for these groups (Garber et al. 2001).
Again, using the same clustering methodology as in the publication (Garber et al.
2001), we apply this technique to their AC data and work with the resulting hierarchical
structure for assessing the local and global p-values. The dendrogram in Figure 2.3
details the hierarchical clustering of the data (for the 24 AC samples from patients with
reported survival information) for steps zero through 22. For each step in the hierarchy
we calculate a log-rank statistic and the corresponding local p-value (m = 100,000
permutation samples). Figure 2.4 graphically presents these local p-values. We exclude
the first two clustering steps (0 and 1) from the figure and further assessments because
insufficient variability in the log-rank statistic at these steps does not permit meaningful
calculation of local p-values. (At the zeroth step of clustering, each patient from the
survival analysis is in his/her own group.) At step 22, we observe the minimum local
p-value of 0.0002, and we calculate the global p-value for this dataset to be 0.0027.
Thus, the experiment shows a statistically significant result, and clustering was effective.
It reduced the initial p-value of 0.0306 at step 2 to the global significance level of
pmin = 0.0027.
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Figure 2.3 Dendrogram created by clustering data from Garber et al. (Garber et al. 2001)

Legend for Figure 2.3:

This schematized dendrogram reflects the process of clustering

microarray samples according to the similarity of their gene expression profiles as measured by
the Pearson correlation coefficient. Distances between array sample clusters are approximated
(not to scale) by the vertical axis. Along the bottom of the dendrogram are the microarray tissue
samples from individuals for which survival data was available (Garber et al. 2001).
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Figure 2.4 Results from log-rank tests applied to steps of the hierarchical structure

formed by clustering data from Garber et al. (Garber et al. 2001)
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Legend for Figure 2.4: This bar graph displays the local p-values we computed at each step
within the structure created by hierarchical clustering.

Example 3 (lymphoma data). The third dataset contains expression levels of

cDNA clones from genes expressed in germinal center B-cells for 47 samples of diffuse
large B-cell lymphoma (DLBCL) (Alizadeh et al. 2000). Hierarchical clustering was
performed with the CLUSTER program and the Pearson correlation coefficient as its
similarity measure to group the samples by similarity of gene expression levels for all
genes expressed in germinal center B-cells. The resulting dendrogram shows two main
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branches, one containing samples with expression patterns similar to those of germinal
center B-cells and one containing samples with expression patterns similar to those of
activated B-cells. To examine the clinical relevance of this subdivision of DLBCL, a
Kaplan-Meier survival analysis for the two groups of patients was performed based on
the dendrogram’s penultimate clustering step (Alizadeh et al. 2000).
As with the other datasets, we cluster the data with the same method as published
(Alizadeh et al. 2000) and use the resulting hierarchical structure for calculations of logrank statistics and associated local p-values (m = 100,000 permutation samples) at
different steps in the hierarchy. The dendrogram in Figure 2.5 provides the order of
clustering (for the 40 DLBCL samples from patients with reported survival information)
for steps zero through 39 while Figure 2.6 graphically presents local p-values at the
different clustering steps. As in Example 2, we observe a very small variance in the logrank statistic at the first two clustering steps and, therefore, exclude these steps from
further analysis. At step 6, we observe the minimum local p-value of 0.0011, with an
associated global p-value of pmin = 0.0167. This result is statistically significant at the 5%
level, and clustering has contributed to an increase in significance because un-clustered
or only minimally clustered data show much lower significance (higher p-value).
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Figure 2.5 Dendrogram created by clustering data from Alizadeh et al. (Alizadeh et al.

2000)

Legend for Figure 2.5:

This schematized dendrogram reflects the process of clustering

microarray samples according to the similarity of their gene expression profiles as measured by
the Pearson correlation coefficient. Distances between array sample clusters are approximated
(not to scale) by the vertical axis. Along the bottom of the dendrogram are the microarray tissue
samples from individuals for which survival data was available (Alizadeh et al. 2000).
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Figure 2.6 Results from log-rank tests applied to steps of the hierarchical structure
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Legend for Figure 2.6: This bar graph displays the local p-values we computed at each step
within the structure created by hierarchical clustering.

Validation of the algorithm.

We found agreement between our original

algorithm for determining pmin and the global p-value determined with the analytical
approach (see section 2.2). Applying the analytical approach for the two-step dataset (see
Table 2.2) resulted in a global p-value of 0.026 while our original algorithm computed
pmin to be 0.023. The 95% confidence interval for this estimate is [0.020, 0.026]. For the
nine-step dataset (see Table 2.3), the analytical approach produced lower and upper
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bounds for pmin of 0.248 and 0.657, respectively. Our original algorithm computed pmin to
be 0.371. A set of naïve bounds can also be created. By assuming perfect pair-wise
correlation between tests, one finds the lower bound to be the minimum p-value, which
for the nine-step dataset was 0.149. In contrast, by assuming the tests at each step to be
independent of one another, one finds the upper bound to be the Bonferroni corrected pvalue, which for the nine-step dataset was 1.0. Thus, the bounds established by using the
multivariate normal distribution were a substantial improvement over the naïve bounds.

2.4

Discussion
In hierarchical clustering, evaluating the minimum local p-value in isolation,

outside of the context of the larger hierarchical structure used to create the data, can
drastically affect the interpretation of test results.

For example, even though the

haplotype data show an apparently significant result with a minimum p-value of 0.0292,
our analysis demonstrates that clustering the same data, but without association between
haplotypes and disease, has a high chance of obtaining such a “significant” result. In
fact, that chance is pmin = 0.1328, which represents the actual significance level of the
experiment. On the other hand, as examples 2 and 3 show, clustering can improve the
significance of a result and provide a result that is statistically significant.
How can we explain that in some cases clustering is beneficial while in other
cases it is not? Presumably, some datasets possess an underlying heterogeneity; that is,
such datasets are composed of samples from multiple distinct populations.

If the

information used for clustering (haplotypes for example 1 and gene expression patterns
for examples 2 and 3) is related to the information used to perform the statistical test (in
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our examples, proportions of cases to controls and survival times), hierarchical clustering
will detect the heterogeneity. Otherwise, the clustering process is random and any
heterogeneity detected is artificial. Our approach allows one to distinguish between these
two situations. If the clustering process is random because the information used for
clustering and test statistic are unrelated (or because the dataset is homogeneous), a large
pmin will result indicating that any small local p-values probably occurred only by chance.
In contrast, if the clustering process is directed by a measurement strongly related to the
test statistic, a small pmin will result indicating that any heterogeneity found within the
hierarchy is most likely real.
Often when hierarchical clustering is applied to a dataset, it is of interest to
determine the true number of classes present. This situation commonly arises in the
analysis of microarray data. For instance, as in examples 2 and 3, in the study of human
cancers, researchers often utilize microarray expression data to cluster samples. From the
hierarchical structure created by clustering, it may be of interest to distinguish the
optimum number of tumor subclasses that are most clinically relevant. Several statisticsbased methods have been utilized to estimate the true number of groups from such
microarray expression datasets (Horimoto and Toh 2001; Dudoit and Fridlyand 2002).
However, such methods rely solely on the expression data itself. Alternatively, it may
prove practical in such microarray expression studies to consider additional information
available, such as survival data, for each sample to distinguish clinically relevant
subclasses. Employing our procedure of calculating the local p-values for a test statistic
at multiple steps within the hierarchy and then selecting the step where the minimum of
these p-values occurs as the basis for determining the true number of classes which exist
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for a given dataset may provide an advantage over existing methods. Of course, if such a
method for determining the true number of classes is applied, the global p-value will
provide an assessment of its significance. However, applying our procedure to some
datasets, such as the data in Example 3, results in determining a large number of true
classes. In fact, the number of classes determined may be so large that the use of these
expression-based tumor subclasses in clinical diagnosis may not provide a benefit.
Therefore, in order to increase the practicality of our method, it may prove necessary to
eliminate some of the lower steps in the hierarchy from eligibility for selecting the
minimum local p-value and the calculation of its significance.
Besides determining subclasses for biological samples, hierarchical clustering is
often employed in the context of microarray expression studies in order to identify groups
of genes that are regulated in a similar manner. In these cases, clustering is performed on
the genes rather than on the samples. Our method relies on two sets of data – one for
clustering and a second for the statistical test. Since the samples possess both expression
data across genes and survival data, our method is applicable to hierarchies created by
clustering on samples. However, genes only possess expression data across samples, and,
consequently, our method is inappropriate for analyzing the significance of hierarchies
created by clustering on genes.
Our approach may be viewed as a contribution to the problem of multiple testing.
We address this problem by defining a single experiment-wise statistic whose associated
empirical significance level represents the overall significance of the experiment. For the
cases we have examined, the experiment refers to performing a test at each step in a
hierarchy created by clustering. However, the meaning of experiment can be expanded to
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reflect other practices adopted by researchers. For example, researchers may apply
several clustering algorithms involving various combinations of clustering methods and
distance measures before finalizing their choice of clustering algorithm.

Since this

practice introduces an additional test at each step within each of the trial hierarchies, it
compounds the effect of multiple testing. Additionally, in some situations researchers
may be interested in testing for heterogeneity among groups with multiple measurements.
For instance, when searching for clinically relevant subclasses of cancer, researchers may
examine groups for differences in survival times as well as differences in physical
characteristics of the tumor cells. Both sets of information may be clinically relevant;
however, to correct for the additional testing, the meaning of the experiment in
calculating pmin must be expanded to reflect the entire process employed by the
researcher. Of course, it is possible that the process of hierarchical clustering forms
medically relevant groups that do not display heterogeneity for any of the measurements
collected. In this case, our strategy will not find these groups as the true grouping
structure for the samples.
Several other methods addressing multiple comparison problems have been
proposed and are in current use.

In particular, as an alternative to the classical

significance level, p, the false discovery rate (FDR) has become rather popular (Reiner et
al. 2003). However, it is important to keep in mind that p and FDR are not really
comparable.

The classical significance level, p, is the conditional probability of a

significant test result given the null hypothesis is true (the expected proportion of false
positive results among all “false” results, i.e., results obtained under the null hypothesis)
while FDR is the conditional probability of the null hypothesis being true given a
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significant test result (the expected proportion of false positive results among all
“positive” results, i.e., significant test results). Future research will have to determine
which of these various approaches to eliminate the effects of multiple testing is most
effective.
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CHAPTER 3: ARE MOLECULAR HAPLOTYPES WORTH IT? A
COST EFFECTIVE METHOD FOR TREATING
MISCLASSIFICATION IN HAPLOTYPE-BASED ASSOCIATION

3.1

Introduction
While clustering haplotype data may create a situation that requires correction for

the multiplicity of testing, other haplotype-based association studies in which no
clustering is employed face complications as well. One such complication is the issue of
haplotype misclassification.
Although recent advances in molecular biology have produced techniques to
unequivocally ascertain phased haplotypes (Michalatos-Beloin et al. 1996; Clark et al.
1998; Yan et al. 2000; Douglas et al. 2001; Patil et al. 2001; Burgtorf et al. 2003; Ding
and Cantor 2003; Horan et al. 2003; Hoppe et al. 2004; Proudnikov et al. 2004; Hoppe et
al. 2006), such molecular haplotyping techniques are seldom employed due to their
expense and incongruity to automation. A more pragmatic alternative is to estimate
haplotype frequencies or infer haplotype pairs by applying statistical methods to
multilocus genotypes (Clark 1990; Xie and Ott 1993; Terwilliger and Ott 1994; Excoffier
and Slatkin 1995; Hawley and Kidd 1995; Long et al. 1995; Zhao et al. 2000; Stephens et
al. 2001b; Zhao and Sham 2002; Stephens and Donnelly 2003). Although knowledge of
parental genotypes can simplify the problem, for haplotype-based association studies the
sample design generally calls for collecting DNA on unrelated individuals, and, in this
case, the statistical methods for haplotype estimation must consider each individual as an
independent observation.
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For these non-familial study designs, several methods are available to estimate
haplotype frequencies and/or infer haplotype pairs. The main methods follow one of two
approaches—1) relying on the EM algorithm (Dempster et al. 1977) for a likelihood
approach (Xie and Ott 1993; Excoffier and Slatkin 1995; Hawley and Kidd 1995; Long et
al. 1995) and 2) using a Bayesian approach to apply a prior based on coalescence theory
(Stephens et al. 2001b; Stephens and Donnelly 2003) or a Dirichlet prior (Niu et al.
2002). The EM algorithm-based methods are implemented in SNPHAP (see Electronic
Resource Information), HAPLO (Hawley and Kidd 1995), and PL-EM (Qin et al. 2002)
while the Bayesian approaches are implemented in PHASE (Stephens et al. 2001b) (see
Electronic Resource Information) and HAPLOTYPER (Niu et al. 2002).

Several

investigators have examined the accuracy of these approaches for both haplotype
frequency estimation and haplotype inference (Fallin and Schork 2000; Tishkoff et al.
2000; Clark et al. 2001; Xu et al. 2002; Stephens and Donnelly 2003; Adkins 2004; Kang
et al. 2004; Niu 2004; Xu et al. 2004; Heid et al. 2005; Sabbagh and Darlu 2005; Zhang
et al. 2005; Marchini et al. 2006; Proudnikov et al. 2006).
Many statistical methods are available to perform tests of haplotype-based casecontrol association. One method calculates the likelihood of the data in terms of the
estimated haplotype frequencies.

An alternative method relies on the use of a

contingency table containing the case-control counts for each inferred haplotype. Since it
applies the same format as the classic genotypic and allele case-control studies and
accounts for each phased haplotype explicitly, many researchers prefer the latter
approach. One can determine the counts in the contingency table by inferring phased
haplotypes for each individual (or by multiplying each haplotype frequency estimate by
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the total number of haplotypes in the study). Once the contingency table contains the
haplotype (or diplotype) counts, a Pearson χ2 test or a likelihood ratio test can be
performed. However, the counts entered in the contingency table may misrepresent the
true situation since inferred haplotypes (and haplotype estimates) are prone to errors.
These haplotype misclassification errors may affect the behavior of the statistical test
performed.
Thus, the purpose of this work is to address the effects of haplotype
misclassification on the false positive rate and power of commonly used tests of
haplotype-based association. Specifically, this research aims to 1) classify the nature of
the misclassification present in calling phased haplotypes; 2) determine the
appropriateness of using the asymptotic χ2 distribution and permutation methods to
evaluate the significance of the test statistics we employ; and 3) compare the power of
our test statistic which accounts for haplotype misclassification with the power of the
standard likelihood ratio test statistic when the costs are fixed.

3.2

Methods
Test statistics. In order to detect an association between a haplotype pair and

disease status, we employed two statistical tests on 2 × k contingency tables where k is
the number of haplotype pair categories found by inference. These tests include the
standard likelihood ratio test (LRTstd) and a likelihood ratio test that employs a doublesampling approach to allow for the misclassification inherent in the haplotype inference
procedure (LRTae).

The LRTstd is a likelihood ratio statistic that treats the called

haplotype pairs as observations, and as a result the likelihood is the multinomial
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distribution where the called haplotype pairs are the categories (Agresti 1996).

The

LRTae statistic is a likelihood ratio statistic that employs a double-sampling procedure to
account for the misclassification present in a haplotype inference. On all the individuals
in the study, there is a fallible measure (Tenenbein 1970; Tenenbein 1972), the haplotype
pairs inferred from the multilocus genotypes, and on a subset of these individuals, there is
a second measure which is considered to be infallible (Tenenbein 1970; Tenenbein 1972),
molecular haplotypes. By comparing the fallible data with infallible data, the LRTae
procedure estimates the misclassification rates present in the fallible data and
incorporates this information into the likelihood calculation (Gordon et al. 2004).

Computation of the LRTstd and LRTae statistics. For completeness, details

regarding the LRTstd and LRTae statistics including notation and computation as
described by Gordon et al. are provided in this section. We present the mathematical
basis for computation of the LRTstd and LRTae statistics. This work largely follows from
the original publication on the LRTae statistic (Gordon et al. 2004).

The primary

difference is that, in this work, we assume only misclassification in haplotype pairs
(called “genotypes” in the original publication) and assume no misclassification of
phenotype. Because we do not collect a second phenotype measurement, we assume that
all phenotype classifications are correct. We begin with some notation.
Notation. For all terms, the index i ' is either 0 (case) or 1 (control) and the

integer indices j and j ' range from 1 through k inclusive, where k is the number of

haplotype pairs.
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We use prime superscripts to distinguish true categories from observed categories.
For example, j ' refers to the true haplotype pair classification for an individual. Also, we
use the superscript t to denote “true” (as compared with observed) when referring to
either an event or a parameter. For example, the notation X tj ' represents the event that an
individual’s true haplotype pair classification is j ' , whereas the notation X j represents
the event that an individual’s observed haplotype pair classification is j (see below).
Similarly, the notation p it' j ' represents the true probability of the haplotype pair j ' for
individuals with (true) phenotype classification i ' , whereas the notation pi ' j represents
the observed probability of the haplotype pair j for individuals with (true) phenotype
classification i ' . With this notation, we may distinguish between the events X 0t and
t
X 0 and the probabilities p01
and p01 .

ni('1j)' j = Number of individuals with (true) phenotype category i ' , true haplotype pair

category j ' , and observed haplotype pair category j . (These individuals are doublesampled on haplotype pair classification.)
ni('1j)'+ = ∑ ni('1j)' j .
j

ni('2j) = Number of individuals with (true) phenotype category i ' and observed haplotype

pair category j .
ni('2+) = ∑ ni('2j)
j

n+( 2j) = ∑ ni('2j)
i'

n = ∑∑∑ ni('1j)' j + ∑∑ ni('2j) ; Note that n is the total sample size.
i'

j'

j

i'

j
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Yi t' =Event that an individual has phenotype i ' , (i ' = 0,1) .
X j =Event that an individual has observed haplotype pair j ,1 ≤ j ≤ k .
X tj ' =Event that an individual has true haplotype pair j ' ,1 ≤ j ' ≤ k .
X it' j ' =Event that an individual has phenotype i ' , (i ' = 0,1) and true haplotype pair

j ' ,1 ≤ j ' ≤ k .
qit' = Pr(Yi t' ) = True sampling frequency of phenotype i ' .
pi ' j = Pr( X j | Yi t' ) = Observed population frequency of haplotype pair j for individuals

with true phenotype i ' .
pit' j ' = Pr( X tj ' | Yi t' ) = True population frequency of haplotype pair j ' for individuals with

phenotype i ' .
p*t j ' = Pr( X tj ' ) = True population frequency of haplotype pair j ' under the null hypothesis

that p 0t j ' = p1t j ' = p*t j ' .
p* j = Pr( X j ) = Observed population frequency of haplotype pair j under the null

hypothesis that p0t j ' = p1t j ' = p*t j ' .
Note: For each i ' , ∑ pit' j ' = ∑ pi ' j = 1 . Also, q0t + q1t = 1 .
j'

j

θ j ' j = Pr( X j | X j ' )
Note: When j ' ≠ j , these parameters are referred to as misclassification parameters
(Tenenbein 1972; Gordon et al. 2002). We make use of the double-sample data structure
to determine estimates of haplotype pair misclassification values θ j ' j .
misclassification parameter estimates θˆ j ' j are θˆ j ' j = m j ' j / m j ' + (see below).
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The

m j ' j (1 ≤ j , j ' ≤ k ) = The number of individuals that have been classified by the fallible
method as haplotype pair j and by the infallible method as haplotype pair j ' .
m j '+ = ∑ m j ' j .
j

ln( L1, std ) = Log-likelihood of data when not correcting for misclassification, where
haplotype pair frequencies pi ' j are allowed to differ among different phenotype classes
(i.e., p0 j is not necessarily equal to p1 j for every j ) (also see equation 3.1b below).
ln( L0, std ) = Log-likelihood of data when not correcting for misclassification, where
haplotype pair frequencies pi ' j are constrained to be equal among different phenotype
classes (i.e., p0 j = p1 j = p* j for every j ) (also see equation 3.1b).
ln( L1, ae ) = Log-likelihood of data as represented in equation (3.4), where haplotype pair
frequencies pit' j ' are allowed to differ among different phenotype classes. (i.e., p0t j ' is not
necessarily equal to p1t j ' for every j ' )
ln( L0, ae ) = Log-likelihood of data as represented in equation (3.4) below, where haplotype
pair frequencies pit' j ' are constrained to be equal among different phenotype classes. (i.e.,
p0t j ' = p1t j ' = p*t j ' for every j ' )

Log-likelihood of observed data and likelihood ratio test statistics

We compute the log-likelihood of the observed data under the null and alternative
hypotheses, allowing for error. The null hypothesis we test is H 0 : p0t j ' = p1t j ' = p*t j ' for all
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haplotype pairs j ' . The alternative hypothesis is H1 : p0t j ' ≠ p1t j ' for at least one j ' .
Under either hypothesis, we have, by definition, the log-likelihood of the data given by:
ln( Lae ) = ∑∑∑ ni('1j)' j ln[Pr(Yi t' , X j , X tj ' )] + ∑ ∑ ni('2j ) ln[Pr(Yi t' , X j )],
i'

j

j'

i'

(3.1a)

j

where the notation Pr( A, B, C ,...) is the probability of observing event A and event B and
event C and so forth and ni('1j)' j , ni('2j ) represent the counts for different categories of doublesample information (see above for definitions of all notation). For example, ni('2j )' j is the
number of individuals who have been double-sampled for haplotype pair classification
and who have true phenotype classification i ' , true haplotype pair classification j ' , and
observed haplotype pair classification j . In equation (3.1a), the subscript i ' runs over all
phenotype classifications ( 0 ≤ i ' ≤ 1 ) and the subscripts j , j ' run over all haplotype pair
classifications (1 ≤ j , j ' ≤ k ).
When a double-sample has not been collected or when we assume that there is no
error in the data, equation (3.1a) reduces to:
ln( Lstd ) = ∑∑ ni('2j ) ln[Pr(Yi t' , X j )]
i'

j

= ∑∑ ni('2j ) ln( pi ' j qit' )
i'

(3.1b)

j

= ∑∑ ni('2j ) [ln( pi ' j ) + ln(qit' )].
i'

j

A key assumption in our work is that the observed haplotype pair is only dependent on
the

underlying

true

haplotype

pair

Pr( X j | X tj ' , Yi t' ) = Pr( X j | X tj ' ) . It follows that:
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and

not

on

phenotype

so

that

Pr(Yi t' , X j , X tj ' ) = Pr( X j | X tj ' , Yi t' ) Pr( X tj ' , Yi t' )
= Pr( X j | X tj ' ) Pr( X tj ' | Yi t' ) Pr(Yi t' )

(3.2)

= θ j ' j pit' j ' qit' .

Using equation (3.2) and the fact that
Pr(Yi t' , X j ) = ∑ Pr(Yi t' , X j , X tj ' ),

(3.3)

j'

we may rewrite the log-likelihood (3.1a) as:
ln( Lae ) = ∑∑∑ ni('1j)' j ln[θ j ' j pit' j 'qit' ] + ∑∑ ni('2j) ln[∑ θ j ' j pit' j 'qit' ].
i'

j'

i'

j

j

(3.4)

j'

From equation (3.4) we can determine the log-likelihood of the data under H1 using the
EM algorithm estimates of p it' j ' and qit' (see (Gordon et al. 2004)). Similarly, we can
determine the log-likelihood of the data under H 0 using the EM algorithm estimates of
p*t j ' and qit' . The estimates of qit' may differ under the null and alternative hypotheses.

It follows from equation (3.4) that the log-likelihoods ln( L0,ae ) and ln( L1,ae )
(equation (3.1a)) are completely determined by misclassification parameters θ j ' j , the true
parameters pit' j ' , p*t j ' , qit' , and sample counts ( ni('1j)' j , ni('2j) ).

In the previous sentence,

ln( L0, ae ) refers to the situation under the null hypothesis, where the terms pit' j ' in equation
(3.4) are replaced by p*t j ' . In contrast, ln( L1, ae ) refers to situation under the alternative
hypothesis, where the terms pit' j ' in equation (3.4) remain. Our test of H1 versus H 0 is a
likelihood ratio test (Kendall et al. 1994), which we call the likelihood ratio test allowing
for error, or LRTae. It is given by
LRTae = 2[ln( L1, ae ) − ln( L0, ae )],
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(3.5a)

where ln( L1,ae ) and ln( L0,ae ) are determined using equation (3.4) with the EM algorithm
estimates of the various parameters. Asymptotically, LRTae is distributed as χ k2−1 , where
the degrees of freedom (df) are k – 1 for a set of k observed haplotype pairs (Gordon et al.
2004). For small samples or in situations where the asymptotic distribution may not hold,
we can compute p-values via permutation (Gordon et al. 2004; Proudnikov et al. 2006).
The standard likelihood ratio test, denoted LRTstd, that does not make any
correction, has its log-likelihoods computed solely from the observed data. That is,
LRTstd = 2[ln( L1, std ) − ln( L0, std )],

(3.5b)

where the log-likelihoods under the null and alternative hypotheses are computed using
the estimates pˆ i ' j = ni('2j) / ni('2+) , pˆ * j = (n0( 2j) + n1( 2j ) ) / n, qˆi ' = ni('2+) / n , ( ni('2+) = ∑ ni('2j) ) that are then
j

substituted into equation (3.1b) (Rice and Holmans 2003). When there is no correction
for misclassification, there is no need to compute qˆi ' under both the null and alternative
hypothesis, as the terms with qˆi ' will cancel in the expression for the difference of the loglikelihoods (equation (3.5b)).

Permuted and asymptotic p-values. We applied two methods for evaluating the

p-value or statistical significance of each statistic. The first method relies on using the
central χ2 distribution to find the p-value since, according to statistical theory under the
null hypothesis of no association, twice the natural logarithm of the likelihood ratio
follows the central χ2 distribution asymptotically for large sample sizes (Agresti 1996).
In addition, it has been shown that when Cochran’s rule is followed (more than five
observations in each cell of the contingency table), the presence of non-differential
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misclassification does not affect the distribution of the likelihood ratio test statistic under
the null hypothesis of no association (Mote and Anderson 1965; Gordon et al. 2004).
The second method employs permutation testing to generate the distribution of the test
statistic under the null hypothesis and to determine its statistical significance. In this
thesis, p-values found with the former and latter approaches are referred to as asymptotic
p-values and permutation p-values, respectively.

Description of data generation and analysis. To investigate the behavior of

these test statistics for a variety of situations, we applied these statistical tests to many
simulated datasets. Figure 3.1 illustrates the procedure we used to simulate the data and
to evaluate the false positive rate and power at fixed significance levels for each statistic.
For the analysis of each replicate dataset simulated, the multilocus genotype data from
cases and controls were pooled to infer haplotype pairs for each individual. Individuals
were assigned the haplotype pair with the highest posterior probability. The posterior
probability of a given haplotype pair is defined as the probability of that haplotype pair
being the true haplotype pair conditioned on the observed multilocus genotypes. For
example, consider two SNP marker loci where A and a represent the alleles at the first
locus while B and b represent the alleles at the second locus. The posterior probability of
the haplotype pair, AB and ab, can be expressed as
Pr{ AB, ab = true | Aa, Bb = observed } =

Pr{ AB} Pr{ab}
Pr{ AB} Pr{ab} + Pr{ Ab} Pr{aB}

by applying Bayes’ Theorem and simplifying. The EM algorithm can be used to estimate
the probability of each haplotype in the posterior probability expression from multilocus
genotypes.

61

The inferred haplotypes are sufficient for the computation of LRTstd; however,
LRTae requires additional information in the form of molecular haplotypes for a subset of
the individuals in the study. We employed two alternative procedures for selecting
individuals for the double-sample (individuals with molecular haplotypes in addition to
genotypes). In one selection scheme, individuals were selected randomly. In the other
selection scheme, individuals possessing the most ambiguity in their statistically inferred
haplotype pairs were prioritized in selecting the double-sample. Specifically, we doublesampled those individuals with the smallest posterior probabilities associated with their
inferred haplotype pair up to a posterior probability threshold, δ, of 0.85 or until the
number of individuals specified by the maximum double-sample proportion was reached.
Therefore, under this second selection scheme the number of individuals double-sampled
varied between replicate datasets. In this thesis, the former and latter procedures for
determining the double-sample are referred to as random and threshold double-sample
selection, respectively.
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Figure 3.1 Schematic flow chart illustrating the procedure for data simulation and

analysis
A)

Simulate haplotypes from known population frequencies
and arbitrarily assign to cases and controls.

B)

Simulate haplotypes from known frequencies
(conditional on affection status). These conditional
frequencies are based on the selected disease model.

Create
many
replicate
datasets.

Find the p-value
1) permutation
2) asymptotic

Calculate statistics
1) LRTstd
2) LRTae
a) random doublesample selection
b) threshold doublesample selection

Remove phase
leaving only
multilocus
genotypes
for each
individual.

Infer haplotype pairs
for each
individual from
their multilocus
genotypes
(cases and
controls pooled).
1) SNPHAP
2) PHASE

Examine the false positive rate for several significance thresholds
(0.05, 0.01, and 0.001) after all replicates completed.
Legend for Figure 3.1:

This schematic flow chart illustrates the procedure employed for

computing (A) type I error and (B) power by way of data simulation.

Two SNP scenario
Evaluation of false positive rate for permutation and asymptotic p-values. For

the simplest non-trivial case, the scenario where the haplotype under evaluation includes
two SNPs, we applied a fractional factorial design (Box et al. 1978) to perform a
comprehensive study of type I error. For the type I error, haplotype pairs were inferred
using both SNPHAP v 1.3.1 (see Electronic Resource Information) and PHASE v 2.1.1
(Stephens et al. 2001b) (see also Electronic Resource Information). Table 3.1 contains
the fractional factorial design settings for the study of type I error for the scenario
involving two SNP markers. We consider a 1 2 ( 2 g ) fractional factorial design, where
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g = 6. Because of redundancy, we were able to reduce the number of experimental runs
from 32 to 18. For instance, under the null hypothesis of no association, a run with 1000
cases and 250 controls is equivalent to a run with 250 cases and 1000 controls (with all
other factors having equal settings to those for the first run). During each run, 10,000
replicate datasets were simulated. We performed the 18 runs with both of the two
alternative procedures for selecting the double-sample – random and threshold doublesample selection. For the threshold double-sample selection method, δ was 0.85, and the
maximum double-sample proportion was set to the value of α in the fractional factorial
design.

Table 3.1 Fractional factorial design parameter settings for the study of type I error

assuming the haplotype under investigation contains two SNP markers
Description of parameter

Low

High

Number of cases
Number of controls
Minor allele frequency at locus 1
Minor allele frequency at locus 2
LD between locus 1 and 2 (measured by D’)
Proportion of individuals double-sampled (α)

250
250
0.1
0.1
0
0.25

1000
1000
0.5
0.5
0.9
0.75

Legend for Table 3.1: This table presents the settings for all parameters considered in the type I
error simulations assuming the haplotype under investigation contains two SNP markers. We
consider a 1 2 ( 2 g ) fractional factorial design, where g = 6. The number of experimental runs
was reduced from 32 to 18 due to redundancy. D’ is the standardized linkage disequilibrium
measure. The simulations included 10,000 replicates, and haplotype pairs were inferred using
both SNPHAP v 1.3.1 and PHASE v 2.1.1. LRTae was computed with the random and threshold
double-sample selection methods for all 18 runs in the fractional factorial design. For the
threshold double-sample selection method, δ was 0.85, and the maximum double-sample
proportion was set to the value of α in the fractional factorial design.
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To evaluate each test statistic’s ability to maintain the correct type I, we examined
the distribution of the p-values computed for data simulated under the null hypothesis of
no association. We performed two goodness-of-fit tests, the Kolmogorov-Smirnov (KS)
and the Anderson-Darling (AD) tests (DeGroot 1991), to determine whether the p-values
deviate significantly from the standard uniform distribution and examined the false
positive rate for significant thresholds of 0.05, 0.01, and 0.001 .

Evaluation of power for fixed cost. We also evaluated the behavior of these

statistics under the hypothesis that a disease allele at an unobserved locus exists in
linkage disequilibrium (LD) with the haplotype under study. Table 3.2 contains the
factorial design settings for the power study in the scenario involving two SNP markers.
The factorial design includes three factors, disease model, genotype relative risk (Schaid
and Sommer 1993) for the homozygote genotype (R2), and the disease allele frequency
(DAF). Each factor contains two levels. For the disease model factor, the two levels are
a dominant disease model and a multiplicative disease model. The dominant disease
model requires that R2 = R1 while the multiplicative disease model requires that
2

R2 = R1 , where R1 and R2 are the genotype relative risks for the heterozygote and
homozygote genotypes, respectively. Specifically, the genotype relative risks are defined
as the following. If the penetrances, f i , are defined by
f i = Pr(affected | i copies of disease allele) , where i = 0, 1, 2 , the genotype relative
risks, R1 and R2, are defined by
R1 = f 1 f 0 and R2 = f 2 f 0 , respectively (Schaid and Sommer 1993).
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Table 3.2 Factorial design parameter settings for the study of power assuming the

haplotype under investigation contains two SNP markers
Description of parameter

Low

Disease model
dominant
Genotype relative risk of homozygote (R2)
2
Disease allele frequency (DAF)

High
multiplicative
3.5

0.07

0.27

Legend for Table 3.2: This table presents the settings for all parameters considered in the power
simulations assuming the haplotype under investigation contains two SNP markers. We consider
a 2 g factorial design, where g = 3. The dominant disease model requires that R2 = R1 while the
2

multiplicative disease model requires R2 = R1 , where R1 and R2 are the genotype relative risks
for the heterozygote and homozygote genotypes, respectively. For the random double-sample
selection method, the proportion of individuals double-sampled (α) was 0.75 while a haplotype
pair posterior probability threshold (δ) of 0.85 and a maximum double-sample proportion of 0.75
were used for the threshold double-sample selection method.

The cost ratio of molecular

haplotyping to genotyping (r) was 5. For each combination of settings, 1000 replicate datasets
comprised of 500 cases and 500 controls were simulated. The disease prevalence was 0.025; the
LD between the disease allele and the linked haplotype was 0.9 (measured by D’); and the
population haplotype frequencies were 0.05, 0.15, 0.25, and 0.5. The haplotype with a frequency
of 0.05 was linked to the disease allele when DAF = 0.07, and the haplotype with a frequency
0.25 was linked to the disease allele when DAF = 0.27. Haplotype pairs were inferred using both
SNPHAP v 1.3.1 and PHASE v 2.1.1.

As with the study of type I error, we inferred the haplotypes for the power
simulations with both SNPHAP v 1.3.1 and PHASE v 2.1.1.

The proportion of

individuals double-sampled, α, for the LRTae method (random double-sample selection)
was set at 0.75. For the threshold double-sample selection, δ was set at 0.85, and the
maximum double-sample proportion was 0.75. In the power simulations, the conditional
(on case status) haplotype frequencies were found from the specified disease model
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parameters by a method described by Sham and subsequently by De La Vega et al.
(Sham 1998; De La Vega et al. 2005) (also see the Power for Association with Error
(PAWE) website at http://linkage.rockefeller.edu/derek/pawe1.html).

However, we

selected a specific haplotype to be in LD with the disease allele. For completeness,
details regarding the conditional haplotype frequencies including notation and
computation as described by De La Vega et al. (2005) are provided at the end of this
section.

During each run, 1000 replicate datasets comprised of 500 cases and 500

controls were simulated. For these simulations, the disease prevalence was 0.025; the LD
between the disease allele and the linked haplotype was 0.9 (measured by D’ (Lewontin
1964)); and the population haplotype frequencies were 0.05, 0.15, 0.25, and 0.55.
Selection of the specific haplotype in LD with the disease allele depended on the disease
allele frequency (DAF). The haplotype occurring with a frequency most similar to that of
the disease allele was selected. Thus, haplotypes with frequencies of 0.05 and 0.25 were
selected as the variant in LD with the disease when the DAF was set at 0.07 and 0.27,
respectively. As with the evaluation of the false positive rate, we performed all 8 runs
from the factorial design using both random and threshold double-sample selection.
To compare the power of the two test statistics, we evaluated the power of the
statistics under fixed cost conditions.

Since the LRTae requires the additional cost

associated with obtaining molecular haplotypes on a subset of the samples, we reduced
the number of samples when the LRTae statistic was applied so that the same total cost
would be incurred as for the runs with the LRTstd. The reduced sample size for the LRTae
sample was computed using equation (3.6),
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N DS


 Cp
N
+ 1

C
g
,
= 
Cp
+ rα
1+
Cg

(3.6)

where NDS is the sample size for the LRTae; N is the sample size for the LRTstd; Cp is the
cost of phenotyping; Cg is the cost of genotyping; r is the cost ratio of molecular
haplotyping to genotyping (Cmh/Cg); and α is the proportion of individuals in the LRTae
sample which have molecular haplotypes determined (double-sampling proportion). We
consider the phenotyping costs, Cp, to include costs associated with ascertainment and
diagnosis. We illustrate fixed cost sample sizes for the following example. With settings
of Cp/Cg = 25, r = 5, α = 0.75, and N = 1000 for the LRTstd method, then the
corresponding total sample size for the LRTae method, NDS, is 874. The reader should
note that the reduced sample size results from the additional cost incurred by doublesampling 75% of the total sample for the LRTae method. If Cp/Cg = 1000, note this term
will dominate the expression in equation (3.6) and the fixed cost sample size, NDS, will
not differ greatly from the sample size for the LRTstd, N. All power simulations were
performed under fixed cost conditions. Since the double-sample proportion, α, varies
from replicate to replicate when the threshold double-sample selection method is
employed, we first performed several test runs to determine the mean double-sample
proportion, α .

Using α , we computed NDS*, the total sample size for the LRTae

determined from the expectation of α. For a specific disease model, we performed a
comprehensive study of the power difference between the LRTae and LRTstd for the
situation of a haplotype comprised of two SNPs.
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Computation for conditional haplotype frequencies. For completeness, here we

illustrate how the conditional (on case status) haplotype frequencies were computed as
described by De La Vega et al. (2005).
List of notation

Marker Loci:
hi = population haplotype frequency of the ith haplotype (out of w possible haplotypes)
Disease Locus:
pd = allele frequency of disease-causing allele at the disease locus
p+ = allele frequency of the wild-type allele at the disease locus
Disease-Marker Haplotypes:
h+,j = frequency of disease-marker haplotype containing the wild-type allele (+) at the
disease locus and the marker haplotype j. This is the probability that the wild-type allele
is on the same chromosome as a given haplotype j.
hd,j = frequency of disease-marker haplotype containing the disease allele (d) at the
disease locus and the marker haplotype j. This is the probability that the disease allele is
on the same chromosome as a given haplotype j.
Disequilibrium Parameters:
D’ = standardized LD parameter (Lewontin 1964), ( 0 ≤ D' ≤ 1 )
Dmax = min[ p d ( 1 − h z ), p + h z ] , where z is the haplotype selected to be LD with the disease
allele
Penetrances:
f0 = Pr{affected|++ at disease locus}
f1 = Pr{affected|+d at disease locus}
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f2 = Pr{affected|dd at disease locus}
Conditional Probabilities:
I i , j1 , j2 = Pr{individual possesses marker haplotypes j1 and j2|affection status i},
1 ≤ j1 , j 2 ≤ w , i = 0 (affected) or 1 (unaffected)
I i , j3 = Pr{individual possesses marker haplotype j3|affection status i}, 1 ≤ j3 ≤ w , i = 0

(affected) or 1 (unaffected)
Prevalence:

φ = disease prevalence = (1 − p d ) 2 f 0 + 2 p d (1 − p d ) f 1 + p d 2 f 2
LD Pattern and Disease-Marker Haplotype Frequencies:
Because the number of linkage disequilibrium parameters increases as the number
of haplotypes increases (Lewontin 1964), we simplify the analysis by constructing an LD
pattern that, for estimated haplotype frequencies h1 , K , hw , is a function of a single
parameter D’. Note that D’ can vary between 0 and 1, where 0 represents linkage
equilibrium and 1 represents complete linkage disequilibrium. We now describe the LD
pattern for a “selected” haplotype, z, where 1 ≤ z ≤ w . By “selected”, we mean that
haplotype z is in positive LD with the disease allele (occurs in phase with the disease
allele more often than under linkage equilibrium conditions). The LD pattern is given by:
 D' ×Dmax , j = z

LD( j ) =  h j
1 − h × D' ×Dmax ,1 ≤ j ≤ w, j ≠ z
z


(3.7)

Using the LD pattern described above, for the “selected” haplotype z, we write the
following two equations for the disease-marker haplotype frequencies:
h+ , j = p + h j − LD( j ),
hd , j = p d h j + LD( j )
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(3.8)

Since h+,j and hd,j are the probabilities that the jth marker haplotype resides on the same
chromosome as the wild-type and disease allele, respectively, hd , j ≥ h+ , j for j = z (the
haplotype “selected” to be LD with the disease allele).
Applying the definition of conditional probability and the law of total probability, we can
write the conditional haplotype pair frequencies as

[
[

(

)

]

 f 0 h+ , j1 h+ , j2 + f 1 h+ , j1 hd , j2 + hd , j1 h+ , j2 + f 2 hd , j1 hd , j2 φ , i = 0
I i , j1 , j2 = 
 (1 − f 0 )h+ , j1 h+ , j2 + (1 − f 1 ) h+ , j1 hd , j2 + hd , j1 h+ , j2 + (1 − f 2 )hd , j1 hd , j2

(

)

] (1 − φ ) ,i = 1 (3.9)

and the conditional haplotype frequencies as
w

I i , j1 = I i , j1 , j1 + 0.5 ∑ I i , j1 , j2 .

(3.10)

j 2 =1
j1 ≠ j 2

We used these conditional (on case status) haplotype frequencies as the generating
frequencies in our simulations under the alternative hypothesis (power runs). Using the
above equations, we were able to compute these conditional haplotype frequencies from
the disease prevalence (f), the disease allele frequency (pd or DAF), the disease model,
the genotype relative risk for the homozygote (R2), the population haplotype frequencies
(hj), the “selected” haplotype (z), and the LD between the “selected” haplotype, and the
disease allele (measured by D’). For example, suppose we set f = 0.025, pd = 0.07,
R2 = 3.5, h1 = 0.05, h2 = 0.25, h3 = 0.15, h4 = 0.55, z = haplotype 1, and D’ (between d
and the haplotype 1) = 0.9 and use a dominant disease model. Since the dominant disease
model requires that R2 = R1 , the genotype relative risk for the heterozygote (R1) must
also be 3.5.

Using the definitions for the genotype relative risks ( R1 = f 1 f 0 and

R2 = f 2 f 0 ) and the definition of the disease prevalence, we find that f0 = 0.019,
f1 = 0.065, and f2 = 0.065. Then by using the definition of Dmax as well as equations (3.7)
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and (3.8), we find each disease-marker haplotype frequency (h+,j and hd,j). Now with the
penetrances (f0, f1, and f2) and the disease-marker haplotype frequencies (h+,j and hd,j),
we can use equation 3.9 to find the conditional haplotype pair frequencies ( I i , j1 , j2 ).
Finally, applying equation (3.10) we find the conditional haplotype frequencies,
I 01 = 0.123, I 11 = 0.048, I 02 = 0.231, I 12 = 0.250 , I 03 = 0.139 , I 13 = 0.150 , I 04 = 0.508, and
I 14 = 0.551 . Note that the frequency of the “selected” haplotype (haplotype 1) is elevated

in cases (relative to the population frequency for this haplotype) while the frequency of
all other haplotypes is lowered in cases (relative to the populations frequencies for these
haplotypes).

Multi-SNP scenario
Evaluation of false positive rate and power for fixed costs. Through additional

simulations, we investigated the behavior of these statistics when applied to haplotypes
comprised of larger numbers of SNPs. Because these simulations required additional
computational time, we only utilized SNPHAP v 1.3.1 (see Electronic Resource
Information) for inferring haplotypes.

Our simulations were based on haplotype

frequencies from two datasets – 1) a dataset of molecular haplotypes with very high
levels of pair-wise LD between markers (Horan et al. 2003) and 2) a dataset of multilocus
genotypes from the TAP2 gene within the major histocompatibility complex, a region
with low pair-wise LD between markers (International HapMap Consortium 2003;
International HapMap Consortium 2005) (see also Electronic Resource Information),
hereafter referred to as the Horan and HapMap TAP2 datasets, respectively. Figure 3.2
displays the inter-marker LD for each of these two datasets using GOLD plots (Abecasis
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and Cookson 2000).

For the Horan dataset, we determined the generating population

haplotype frequencies for our simulations directly using the counting method (Ott 1999).
For the HapMap TAP2 dataset, we found the generating population haplotype
frequencies for our simulations indirectly using SNPHAP v 1.3.1 (see Electronic
Resource Information). In the latter case, haplotype frequencies were estimated from the
parents of each trio in the Yoruba population group from the International HapMap
Project. For the type I error simulation studies, 1000 replicate datasets containing 250
cases and 250 controls were simulated. For the type I error runs based on the Horan data
and the HapMap TAP2 data, we simulated haplotypes comprised of 15 SNPs and 10
SNPs, respectively, while for the power runs, we simulated haplotypes comprised of 5
SNPs (Horan et al. 2003; International HapMap Consortium 2003; International HapMap
Consortium 2005). Figure 3.2 specifies the SNPs we utilized from each dataset in the
type I error and power runs. For the Horan dataset, we provide the SNP markers’
positions (relative to the transcription start site of the GH1 gene) while for the HapMap
TAP2 dataset, we provide the name of the SNP marker. As a result, we simulated
haplotypes using 17 haplotype variants with frequencies greater than 0.01 for both the
Horan and HapMap TAP2 type I error simulations. In addition, we simulated haplotypes
using 5 and 10 haplotype variants with frequencies greater than 1 ( 2t ) , where t is the
total number of individuals (t = 153 for the Horan dataset and t = 60 for the HapMap
TAP2 dataset), for the Horan and HapMap TAP2 power simulations, respectively. For
each scenario, we normalized the frequencies so that they summed to unity. As with the
power studies for the two SNP scenario, the selection of the specific haplotype in LD
with the disease allele depended on the DAF. The rationale for the selection procedure is
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provided in section 3.3 addressing multi-SNP power. For multi-marker type I error and
power studies, we employed both the random and threshold double-sample selection
methods in computing the LRTae statistic. When the random double-sample selection
method was utilized, the double-sample proportion, α, was 0.75. When the threshold
double-sample method was utilized, the setting of δ = 0.85 was used, and the maximum
proportion of individuals included in the double-sample was 0.75.
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Figure 3.2 GOLD plots for the Horan and HAPMAP TAP2 datasets

Legend for Figure 3.2: These GOLD plots (Abecasis and Cookson 2000) show the pair-wise intermarker LD in terms of D’ for (A) 15 SNP
markers within the proximal promoter region of human pituitary expressed growth hormone (GH1) and (B) 10 SNP markers with the TAP2 gene.
In (A), the SNP markers are listed as their position relative to the transcription start site of the GH1 gene whereas in (B), the SNP markers are
listed by their National Center for Biotechnology Information (NCBI) reference SNP (rs) numbers. Physical distances are provided. All SNP
markers displayed were included in the type I error study while SNP markers accompanied by an asterisk (*) were included in the power study.

Identifying the nature of haplotype pair misclassification.

For all the

simulations performed, we recorded the details of the misclassifications that occurred.
Specifically, for every replicate we computed the misclassification rates,
θ j' j = Pr{observed haplotype pair classification is j| true haplotype classification is j’},

where j ' ≠ j (Gordon et al. 2004). Previous research studying genotype misclassification
rates in tests of genotypic association provides the motivation for ascertaining these
values (Kang et al. 2004). This notation is also used in the description of the LRTstd and
LRTae statistics.

3.3

Results
Two SNP scenario. Our type I error and power results from the simulations

utilizing SNPHAP v 1.3.1 and PHASE v 2.1.1 for the haplotype inference were almost
identical. Although we present graphs and tables that display the results where SNPHAP
v 1.3.1 provided the haplotype inference, the reader should note that similar results were
found using PHASE v 2.1.1 for the haplotype inference.

Evaluation of false positive rates for permutation and asymptotic p-values. The

type I error simulations demonstrated that the approach for determining statistical
significance is critical for maintaining the correct false positive rate. While KS and AD
test results indicated that the distribution of permutation p-values was consistent with the
standard uniform distribution, they indicated that the distribution of asymptotic p-values
did not resemble the standard uniform distribution. These results were reinforced by the
false positive rates we found.

For all the simulation runs displayed in Table 3.1,
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Figure 3.3 shows the false positive rate for various significance thresholds for LRTstd and
LRTae (using the random and threshold double-sample selection methods) association
tests in which statistical significance was indicated by permutation and asymptotic pvalues. The graph in Figure 3.3A shows that asymptotic p-values for LRTae are anticonservative while those for LRTstd fluctuate between conservative and anti-conservative
values when a significance threshold of 0.05 is applied. In contrast, the permutation pvalues for both statistics consistently maintain the nominal significance level of 0.05. We
found that the asymptotic and permuted p-values demonstrated similar behavior for
significance thresholds of 0.01 and 0.001. However, for the 0.001 significance threshold,
the p-values appear more scattered due to the scale at this extreme significance threshold.
Haplotype pairs were inferred using SNPHAP v 1.3.1 for the simulation results displayed
in the graph. These results are not surprising since several simulation parameter settings
have expected cell counts of less than five counts, violating Cochran’s rule (Cochran
1952).
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Figure 3.3 Line graph illustrating estimates of the false positive rate at various

significance levels for LRTstd and LRTae

Legend for Figure 3.3: The line graphs show estimates of the false positive rate at the (A) 0.05
significance level, (B) 0.01 significance level, and (C) 0.001 significance level for LRTstd and
LRTae with p-values determined by both permutation and the asymptotic central χ2 distribution.
The 18 runs correspond to the combinations of parameter settings described in Table 3.1. For all
18 runs, LRTae was computed with the random and threshold double-sample selection methods.
When the threshold double-sample method was utilized to compute LRTae, the setting of δ = 0.85
was used, and the maximum proportion of individuals included in the double-sample was the
value for α specified by the fractional factorial design. Haplotype pairs were inferred using
SNPHAP v 1.3.1 for the simulation results displayed in the graph.
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Evaluation of power for fixed cost. Based on the results for the false positive

rates, we conclude that power can only be evaluated using the permutation p-values. We
compare the power of LRTae (using the random and threshold double-sample selection
methods) to LRTstd. Table 3.3 presents summary statistics for the power difference
(LRTae power – LRTstd power) at various significance levels for the two cost ratios
C p / C g = 25 and C p / C g = 1000 using the 8 parameter settings from the factorial design

(Table 3.2). Note that in all runs, we set the cost ratio of molecular haplotyping to
genotyping, r, to be 5, and the proportion of individuals to be double-sampled, α, to be
0.75 (for the random double-sample selection method). The values reported correspond
to the simulations utilizing SNPHAP v 1.3.1.

79

Table 3.3 Summary statistics for power difference (LRTae – LRTstd) at various significance levels

Significance Level = 0.05
DS
Selection
Method
random
threshold

Significance Level = 0.01

Significance Level = 0.001

Summary
Statistic

C p / C g = 25

C p / C g = 1000

C p / C g = 25

C p / C g = 1000

C p / C g = 25

C p / C g = 1000

minimum
median
maximum
minimum
median
maximum

-0.061
0.004
0.036
-0.010
0.043
0.126

-0.004
0.014
0.105
-0.004
0.045
0.162

-0.062
0.005
0.033
0.001
0.048
0.117

0.001
0.019
0.089
0.003
0.048
0.123

-0.056
-0.007
0.025
-0.001
0.064
0.151

0.000
0.021
0.135
0.000
0.068
0.152

Legend for Table 3.3: This table presents summary statistics for the power difference between the LRTae and LRTstd methods (p-values evaluated
using permutation) at the 0.05, 0.01, and 0.001 significance levels. Results are shown for LRTae computed using both the random and threshold
double-sample selection methods. The methods are compared for fixed costs where the power for LRTae is computed under two conditions, 1) the
cost ratio of phenotyping to genotyping (Cp/Cg) is 25 and 2) the cost ratio of phenotyping to genotyping (Cp/Cg) is 1000. The sample size for
LRTstd, N, is 1000 (500 cases, 500 controls). For the LRTae statistic, settings of α = 0.75 (random double-sample selection method) and r = 5 were
used. When the threshold double-sample selection method was utilized to compute LRTae, the setting of δ = 0.85 was used, and the maximum
proportion of individuals included in the double-sample was 0.75. Haplotype pairs were inferred using SNPHAP v 1.3.1.

For the random double-sample selection method, the minimum power difference
occurred when C p / C g = 25 for a dominant disease model with R2 = 2 and DAF = 0.27 at
a significance level of 0.01. For these settings, the LRTae power was 0.544 and LRTstd
power was 0.606. The maximum power difference occurred when C p / C g = 1000 for a
dominant disease model with R2 = 3.5 and DAF = 0.07 at a significance level of 0.001.
For these settings, the LRTae power was 0.910 and LRTstd power was 0.775.
For the threshold double-sample selection method, the minimum power difference
occurred when C p / C g = 25 for a dominant disease model with R2 = 2 and DAF = 0.27 at
a significance level of 0.05. For these settings, the LRTae power was 0.821 and LRTstd
power was 0.831. The maximum power difference occurred when C p / C g = 1000 for a
dominant disease model with R2 = 2 and DAF = 0.07 at a significance level of 0.05. For
these settings, the LRTae power was 0.573 and LRTstd power was 0.411.

Power difference as a function of double-sample proportion and cost ratio. In

the spirit of response surface analysis for factorial design (Box et al. 1978), we performed
a more thorough analysis of the parameter settings that provided the maximum power
difference when LRTae was computed with the random double-sample selection method.
These parameter settings are a dominant disease model with R2 = 3.5 and DAF = 0.07.
These settings provided the additional benefit of power results greater than 75% for both
the LRTae and LRTstd methods at the 0.05, 0.01, and 0.001 significance levels for both
cost ratios of C p / C g = 25 and C p / C g = 1000 . The analysis involved computation of
the LRTae with the random double-sample selection method. Figure 3.4 displays the twodimensional contour plots of the power difference between the LRTae and the LRTstd as a
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function of r, the cost ratio of molecular haplotyping to genotyping, and α, the proportion
of individuals double-sampled. These power differences are computed for the fixed
parameter settings of C p / C g = 25 (Figure 3.4A) and C p / C g = 1000 (Figure 3.4B) at
significance level = 0.001 for the disease model described immediately above.

The

values of r considered in the contour plots are 1, 5, 10, 25, and 50 while the values of α
considered are 0.25, 0.50, 0.75, and 1.0. One should note that α = 1.0 indicates all
individuals in the study are double-sampled regardless of phase ambiguity. Simulations
were performed with 1000 replicates and 10,000 permutations for each combination of
parameters, and SNPHAP v 1.3.1 was utilized for the haplotype inference. The sample
size for the LRTstd, N, was 1000 (equal numbers of cases and controls).
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Figure 3.4 Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.001 (two SNP scenario)

Legend for Figure 3.4: The contour plots display the power difference between the LRTae and LRTstd at various settings for the cost ratio of
molecular haplotyping to genotyping (r) and the proportion of individuals double-sampled (α). Power is compared at the 0.001 significance level.
The cost ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000. The two SNP scenario
is examined for the parameter settings that provided the maximum power difference for factorial design (Table 3.2) using the random doublesample selection method. Generating haplotype frequencies for cases and controls were based on a dominant disease model with f = 0.025,
R2 = 3.5, and DAF = 0.07, as well as, population haplotype frequencies of 0.05, 0.25, 0.15, and 0.55. The haplotype with a frequency of 0.05 was
placed in LD (D’ = 0.9) with the disease allele. LRTae was only computed with the random double-sample selection method. Haplotype pairs
were inferred using SNPHAP v 1.3.1.

Figure 3.4A shows that the LRTae provides a power advantage over the LRTstd
when r is less than 10 and α is greater than 0.5. The maximum power gain is 0.16 and
occurs when r and α are 1.0. Conversely, when r is greater than 10, LRTae is less
powerful than LRTstd for these parameter settings. The maximum power loss is 0.58 and
occurs when r is 50 and α is 1.0. Note that for these values the total sample available for
the LRTae method, NDS (equation (1)), is 342 while the total sample available for the
LRTstd method, N, is 1000.
Figure 3.4B illustrates that LRTae is always at least as powerful as LRTstd when
C p / C g = 1000 . We observe a minimum power gain of 0.02 when r is 50 and α is 0.25

and a maximum power gain of 0.17 when r and α are 1.0. Furthermore, Figure 3.4B
indicates that for any cost ratio, r, increasing the double-sampling proportion, α, always
increases the power gain with the maximum power gain occurring when α = 1.0.
Figures 3.5 and 3.6 display similar contour plots of the power difference between
the LRTae and the LRTstd (as a function of r, the cost ratio of molecular haplotyping to
genotyping, and α, the proportion of individuals double-sampled) using the same
parameters as above at significance levels of 0.01 and 0.05, respectively. Again, these
power differences are computed for fixed parameter settings of C p / C g = 25
(Figures 3.5A and 3.6A) and C p / C g = 1000 (Figures 3.5B and 3.6B). Figures 3.5 and
3.6 show that the results using significance thresholds of 0.01 and 0.05 are similar to
those using a significance threshold of 0.001 (Figure 3.4). When r is less than 10 (same
as for Figure 3.4A), Figures 3.5A and 3.6A show that LRTae provides a power advantage
over LRTstd. As the significance level increases, the power advantage decreases. Thus,
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the power advantage is greatest for the 0.001 significance level, less for the 0.01
significance level, and least for the 0.05 significance level. Figures 3.5B and 3.6B
illustrate that when C p / C g = 1000 , LRTae is always more powerful than LRTstd at
significance levels of 0.01 and 0.05, respectively. Again, the power advantage decreases
as the significance level increases.
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Figure 3.5 Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.01 (two SNP scenario)

Legend for Figure 3.5: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α). Power is compared at the 0.01 significance level. The cost
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000. The two SNP scenario is
examined for the parameter settings that provided the maximum power difference for factorial design (Table 3.2) using the random double-sample
selection method. Generating haplotype frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and
DAF = 0.07, as well as, population haplotype frequencies of 0.05, 0.25, 0.15, and 0.55. The haplotype with a frequency of 0.05 was placed in LD
(D’ = 0.9) with the disease allele. LRTae was only computed with the random double-sample selection method. Haplotype pairs were inferred
using SNPHAP v 1.3.1

Figure 3.6 Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.05 (two SNP scenario)

Legend for Figure 3.6: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α). Power is compared at the 0.05 significance level. The cost
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000. The two SNP scenario is
examined for the parameter settings that provided the maximum power difference for factorial design (Table 3.2) using the random double-sample
selection method. Generating haplotype frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and
DAF = 0.07, as well as, population haplotype frequencies of 0.05, 0.25, 0.15, and 0.55. The haplotype with a frequency of 0.05 was placed in LD
(D’ = 0.9) with the disease allele. LRTae was only computed with the random double-sample selection method. Haplotype pairs were inferred
using SNPHAP v 1.3.1.

Multi-SNP scenario
Evaluation of false positive rates for permutation and asymptotic p-values.

Table 3.4 displays our estimates of the false positive rate using various significance
thresholds (0.05, 0.01, and 0.001) and the results of the KS test for the Horan and
HapMap TAP2 dataset-based simulations. Again, only the permuted p-values resemble
the standard uniform distribution.

In addition, the permuted p-values maintain the

nominal significance level while the asymptotic p-values are anti-conservative.
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Table 3.4 False positive rate estimates for simulations with generating population

haplotype frequencies based on the Horan and HAPMAP TAP2 datasets
Sig.
Level

p-Value
Type

DS
Statistic Selection False
Method Positive
Rate
LRTstd

asymptotic
0.05

LRTae
LRTstd

permuted

LRTae
LRTstd

asymptotic
0.01

LRTae
LRTstd

permuted

LRTae
LRTstd

asymptotic
0.001

LRTae
LRTstd

permuted

LRTae

N/A
random
threshold
N/A
random
threshold
N/A
random
threshold
N/A
random
threshold
N/A
random
threshold
N/A
random
threshold

0.396
0.500
0.490
0.062
0.053
0.051
0.122
0.181
0.168
0.014
0.010
0.004
0.020
0.033
0.026
0.003
0.003
0.001

Horan Dataset

HAPMAP TAP2 Dataset
False
KS pPositive
Value
Rate

95% C.I.
(0.366, 0.427)
(0.469, 0.532)
(0.459, 0.522)
(0.048, 0.079)
(0.040, 0.069)
(0.038, 0.067)
(0.102, 0.144)
(0.158, 0.206)
(0.145, 0.193)
(0.008, 0.023)
(0.005, 0.018)
(0.001, 0.010)
(0.012, 0.031)
(0.023, 0.046)
(0.017, 0.038)
(0.001, 0.009)
(0.001, 0.009)
(0.000, 0.006)

< 0.001
< 0.001
< 0.001
0.931
0.718
0.143
< 0.001
< 0.001
< 0.001
0.931
0.718
0.143
< 0.001
< 0.001
< 0.001
0.931
0.718
0.143

0.424
0.659
0.632
0.041
0.047
0.048
0.154
0.336
0.314
0.010
0.008
0.012
0.013
0.062
0.070
0.004
0.002
0.000

95% C.I.

KS pValue

(0.393, 0.455)
(0.629, 0.688)
(0.601, 0.662)
(0.030, 0.055)
(0.035, 0.062)
(0.036, 0.063)
(0.132, 0.178)
(0.307, 0.366)
(0.285, 0.344)
(0.005, 0.018)
(0.004, 0.016)
(0.006, 0.021)
(0.007, 0.022)
(0.048, 0.079)
(0.055, 0.088)
(0.001, 0.010)
(0.000, 0.007)
(0.000, 0.003)

< 0.001
< 0.001
< 0.001
0.770
0.665
0.267
< 0.001
< 0.001
< 0.001
0.770
0.665
0.267
< 0.001
< 0.001
< 0.001
0.770
0.665
0.267

Legend for Table 3.4: This table presents estimates of the false positive rate and the
corresponding 95% confidence intervals for the LRTstd and LRTae statistics (asymptotic and
permuted p-values) for various significance levels.

The generating population haplotype

frequencies for the simulations were based on the Horan and HAPMAP TAP2 datasets (as
described extensively in the Methods section). Simulations for 1000 replicate datasets containing
250 cases and 250 controls were performed. LRTae was computed with the random and threshold
double-sample selection methods.

When the random double-sample selection method was

utilized, a setting of α = 0.75 was used. When the threshold double-sample method was utilized
to compute LRTae, the setting of δ = 0.85 was used, and the maximum proportion of individuals
included in the double-sample was 0.75. The table also displays p-values for the KolmogorovSmirnov Test (KS Test) which tests the null hypothesis that the p-values computed for each
statistic are drawn from a standard uniform distribution. Haplotype pairs were inferred using
SNPHAP v 1.3.1.
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Evaluation of power for fixed cost. In our power study for haplotypes comprised

of five SNPs, we again utilized the disease model parameter settings that provided the
maximum power difference (LRTae power – LRTstd power) for the two SNP factorial
design (Table 3.2) with LRTae computed using random double-sample selection. These
parameter settings are a dominant disease model with R2 = 3.5 and DAF = 0.07. We
based the population haplotype frequencies on the Horan and HapMap TAP2 datasets as
described in the Methods section. For each dataset, we selected the haplotype with a
frequency closest to 0.05 as the haplotype in LD with the disease allele. By this choice of
haplotype, we approximated the frequency of the linked haplotype for the two SNP
scenario (see section 3.2) when DAF = 0.07. As with two SNP power study, the LD
between the disease allele and the linked haplotype was 0.9 (measured by D’) (Lewontin
1964).

The cost ratio of molecular haplotyping to genotyping (r) was 5. When the

random double-sample selection method was utilized to compute LRTae, the doublesample proportion (α) was 0.75. When the threshold double-sample method was utilized
to compute LRTae, the setting of δ = 0.85 was used, and the maximum proportion of
individuals included in the double-sample was 0.75.
For the Horan dataset, the power estimates for LRTstd and LRTae were almost
identical at the 0.05, 0.01, and 0.001 significance levels for cost ratios ( C p / C g ) of both
1000 and 25 (results not shown). The high pair-wise intermarker LD present in the
Horan dataset causes the haplotype inference to occur with almost complete fidelity. In
the absence of misclassification, the LRTae statistic reduces to LRTstd. Therefore, the
high degree of similarity in power for these statistics is not surprising.
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For the HAPMAP TAP2 dataset, Table 3.5 displays the power estimates and the
corresponding 95% confidence intervals for the LRTstd and LRTae methods at the 0.05,
0.01, and 0.001 significance levels assuming fixed costs. When C p / C g = 1000 , LRTae
provides a substantial power benefit over LRTstd with the power difference ranging from
6% and 7% at a significance level of 0.05 to 14% and 21% at a significance level of
0.001 for random double-sample selection and threshold double-sample selection,
respectively. When C p / C g = 25 , the advantage of LRTae over LRTstd is still substantial
for threshold double-sample selection but more modest for random double-sample
selection. For the three significance levels under investigation, the power difference
ranged from 7% to 22% and 1% to 3.5% for threshold and random double-sample
selection, respectively.
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Table 3.5 Power estimates for simulations with generating population haplotype

frequencies based on the HAPMAP TAP2 datasets
DS
Significance
Statistic Selection Cp/Cg
Level
Method
LRTstd
0.05

N/A
random

LRTae
threshold
LRTstd

0.01

N/A
random

LRTae
threshold
LRTstd

0.001

N/A
random

LRTae
threshold

Power

95% C.I.

N/A

0.858 (0.835, 0.879)

1000

0.919 (0.900, 0.935)

25

0.868 (0.845, 0.888)

1000

0.924 (0.906, 0.940)

25

0.935 (0.918, 0.950)

N/A

0.666 (0.636, 0.695)

1000

0.801 (0.775, 0.825)

25

0.701 (0.672, 0.729)

1000

0.804 (0.778, 0.828)

25

0.817 (0.792, 0.841)

N/A

0.405 (0.374, 0.436)

1000

0.546 (0.515, 0.577)

25

0.421 (0.390, 0.452)

1000

0.613 (0.582, 0.644)

25

0.626 (0.595, 0.656)

Legend for Table 3.5: This table presents power estimates and the corresponding 95% confidence
intervals for LRTstd and LRTae statistics (permuted p-values) at various significance levels. The
simulations were performed under fixed costs such that the number of samples when LRTae is
applied is reduced according to equation (3.6). The generating population haplotype frequencies
for the simulations were based on the HAPMAP TAP2 dataset (as described extensively in the
Methods section). The disease model is dominant with R2 = 3.5, disease prevalence = 0.025,
DAF = 0.07, and D’ between the disease allele and the associated haplotype = 0.9. Settings of

α = 0.75 (random double-sample selection method) and r = 5 were used. When the threshold
double-sample method was utilized to compute LRTae, the setting of δ = 0.85 was used, and the
maximum proportion of individuals included in the double-sample was 0.75. Haplotype pairs
were inferred using SNPHAP v 1.3.1.
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We found that the median power gain of LRTae over LRTstd for the threshold
double-sample selection method was consistently greater than that for the random
double-sample selection method for the runs associated with the factorial design settings
displayed in Table 3.2 and the HAPMAP TAP2 power simulations (see Tables 3.3 and
3.5). Furthermore, the power gain for the threshold double-sample selection method
occurred for either setting of C p / C g . For the threshold double-sample selection method,

α was small (less than 21%) in our simulations so that our computed NDS* corresponded
to 963 individuals.
Power difference as a function of double-sample proportion and cost ratio. As

we did for the two SNP scenario, we performed a more thorough analysis to explore the
effect of varying the cost ratio of molecular haplotyping to genotyping (r) and the doublesample proportion (α) on the power difference between LRTae and LRTstd for the multiSNP scenario. Again, we used the parameter settings of a dominant disease model with
R2 = 3.5 and DAF = 0.07. As before, f was set to 0.025, and the haplotype with a

frequency closest to 0.05 was placed in LD (D’ = 0.9) with the disease allele. The
population haplotype frequencies were those from the HAPMAP TAP2 dataset
(haplotype comprising 5 SNPs). The analysis involved computation of LRTae with the
random double-sample selection method. Figures 3.7, 3.8, and 3.9 display the twodimensional contour plots of the power difference between LRTae and LRTstd as a
function of r and α at significance levels of 0.001, 0.01, and 0.05, respectively. These
power differences are computed for the fixed parameter settings of C p / C g = 25
(Figures 3.7A, 3.8A, and 3.9A) and C p / C g = 1000 (Figures 3.7B, 3.8B, and 3.9B). The
values of r considered in the contour plots are 1, 5, 10, 25, and 50 while the values of α
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considered are 0.25, 0.50, 0.75, and 1.0.

Simulations were performed with 1000

replicates and 1000 permutations for each combination of parameters, and
SNPHAP v 1.3.1 was utilized for the haplotype inference. The sample size for LRTstd, N,
was 1000 (equal numbers of cases and controls).
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Figure 3.7 Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.001 (multi-SNP scenario)

Legend for Figure 3.7: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α). Power is compared at the 0.001 significance level. The cost
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000. Generating haplotype
frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and DAF = 0.07, as well as, population
haplotype frequencies found from the HAPMAP TAP2 dataset (haplotype comprising 5 SNPs). The haplotype with a frequency closest to 0.05
was placed in LD (D’ = 0.9) with the disease allele. LRTae was only computed with the random double-sample selection method. Haplotype pairs
were inferred using SNPHAP v 1.3.1.

Figure 3.8 Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.01 (multi-SNP scenario)

Legend for Figure 3.8: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α). Power is compared at the 0.01 significance level. The cost
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000. Generating haplotype
frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and DAF = 0.07, as well as, population
haplotype frequencies found from the HAPMAP TAP2 dataset (haplotype comprising 5 SNPs). The haplotype with a frequency closest to 0.05
was placed in LD (D’ = 0.9) with the disease allele. LRTae was only computed with the random double-sample selection method. Haplotype pairs
were inferred using SNPHAP v 1.3.1.

Figure 3.9 Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.05 (multi-SNP scenario)

Legend for Figure 3.9: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α). Power is compared at the 0.05 significance level. The cost
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000. Generating haplotype
frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and DAF = 0.07, as well as, population
haplotype frequencies found from the HAPMAP TAP2 dataset (haplotype comprising 5 SNPs). The haplotype with a frequency closest to 0.05
was placed in LD (D’ = 0.9) with the disease allele. LRTae was only computed with the random double-sample selection method. Haplotype pairs
were inferred using SNPHAP v 1.3.

Like the two SNP scenario, Figures 3.7, 3.8, and 3.9 illustrate that for the multiSNP scenario the power difference between LRTae and LRTstd increases as the
significance threshold decreases.

Figures 3.7A, 3.8A, and 3.9A show that LRTae

provides a power advantage over LRTstd when r is less than 5 and α is greater than 0.5
when significance thresholds of 0.001, 0.01, and 0.05, respectively, are applied. In each
case a maximum power gain (0.182 for the 0.001 significance level, 0.153 for the 0.01
significance level, and 0.084 for the 0.05 significance level) occurs when r and α are 1.0.
Conversely, when the r is greater than 5, LRTae is less powerful than LRTstd for these
parameter settings.
Figures 3.7B, 3.8B, and 3.9B show that LRTae is almost always at least as
powerful as LRTstd when C p / C g = 1000 for the multi-SNP scenario. We observe a
slight power loss of 0.02 at the 0.001 significance level when α = 0.25 and r = 10 and of
approximately 0.01 at the 0.01 and 0.05 significance levels when α = 0.25 and r = 5. The
maximum power gain of 0.217 occurs when r and α are 1.0 using a significance threshold
of 0.001 (Figure 3.7B). As we observed with the two SNP scenario, Figures 3.7B, 3.8B,
and 3.9B indicate that for any cost ratio, r, increasing the double-sampling proportion, α,
always increases the power gain with the maximum power gain occurring when α = 1.0.
Furthermore, comparing the multi-SNP scenario (Figures 3.7, 3.8, and 3.9) with
the two SNP scenario (Figures 3.4, 3.5, and 3.6), we find the same fundamental trends for
both C p / C g = 25 and C p / C g = 1000 .

However, the multi-SNP scenario generally

displays a larger power advantage for LRTae over LRTstd due to the greater opportunity
for misclassification of haplotypes composed of more double heterozygotes.
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3.4

Discussion
In practice, few researchers employ molecular haplotyping techniques in genetic

case-control studies. The absence of a high-throughput procedure relative to current SNP
genotyping technologies is arguably the main reason that this methodology is not more
widely used. Another related reason is the cost in terms of both time and money
associated with employing this methodology. Our research suggests that the additional
costs involved in molecular haplotyping may be worth the effort, especially if the cost of
phenotyping is high relative to the cost of genotyping for a study. Ji et al. found
analogous results for the effects of genotype misclassification on genotypic tests of
association (Ji et al. 2005). Other research has shown that molecular haplotypes can
greatly increase the power of family-based linkage studies for mapping complex diseases
(Gillanders et al. 2006). In practice, the situation where the cost of phenotyping is high
relative to the cost of genotyping arises for replication studies. A genome-wide scan
involving thousands of SNP markers along with subsequent fine mapping in an initial set
of case and control individuals may identify a number of promising regions for follow-up
studies. These follow-up or replication studies involve recruiting an independent sample
of cases and controls for which only SNPs in the promising regions will be genotyped
(Skol et al. 2006). In replication studies for complex traits, the cost ratio of phenotyping
to genotyping may be on the order of thousands. For these situations, the LRTae for
testing haplotype association should provide the most utility. It is interesting to note,
however, that applying the threshold double-sample selection method provided
comparable powers for both high and low phenotyping to genotyping cost ratios. This
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finding suggests that this selection strategy may provide additional power for an initial
genome-wide association study as well as for a replication study.
One potential limitation of the test statistics that we selected is the increase in
degrees of freedom associated with using haplotype pairs rather than individual
haplotypes. In general, larger degrees of freedom may result in a loss of power. That is,
methods that fully account for uncertainty in the phase assignment process (Schaid et al.
2002; Zaykin et al. 2002; Stram et al. 2003) may be more powerful than LRTae because
the LRTae method examines haplotype pairs rather than single haplotypes and therefore
has more degrees of freedom. We chose these statistics for the following reasons: 1) The
most general misclassification model involves modeling errors in haplotype pairs rather
than in individual haplotypes (Douglas et al. 2002; Sobel et al. 2002; Gordon et al. 2004).
2) When haplotype pair frequencies deviate from Hardy Weinberg Equilibrium in either
case or control sample populations, test statistics that utilize single haplotype frequencies
may increase false positive rates and/or lose power (Sasieni 1997; Czika and Weir 2004).
3) In contrast with methods that utilize single haplotype frequencies, the CochranArmitage Linear Test of Trend maintains the nominal false positive rate and does not lose
power (Cochran 1954; Armitage 1955; Czika and Weir 2004). To our knowledge, a
version of this test that incorporates double-sampling procedures to correct for haplotype
miscalls does not currently exist.
A point for further research involves identifying the scenarios that produce
differential and non-differential haplotype pair misclassification as well as the effects of
each kind of misclassification on type I error and power. Under the null hypothesis that
haplotype frequency distributions are equal in case and control populations, theoretical
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and simulation studies (including the work presented in this chapter) suggest that
misclassification is non-differential. Under the alternative hypothesis, it is conceivable
that haplotype pair misclassification rates may be different in case and control
populations. While recent research (Clayton et al. 2005; Moskvina et al. 2006) indicates
that differential misclassification increases the type I error, the effects of differential
misclassification on the power of these statistics remain unclear.
While the current perception may be that molecular haplotyping costs are not
cost-effective, recent publications suggest that for relatively small regions of the genome
accurate molecular haplotyping is no more expensive than performing fluorescent
polymerase chain reactions (Proudnikov et al. 2004; Proudnikov et al. 2006). In addition,
current techniques are able to provide molecular haplotypes for an entire chromosome at
a cost ratio (Cmh/Cg) of approximately 5 (C. Ding; personal communication). Finally, as
technology improves, the costs associated with molecular haplotyping will likely
decrease, and the throughput will likely increase.
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CHAPTER 4: ASCERTAINING THE DISTRIBUTION FOR THE
LIKELIHOOD RATIO STATISTIC

4.1

Introduction
Although haplotype misclassification can decrease the power for a study, the issue

can be avoided by applying an approach that does not infer haplotype pairs for each study
participant. An alternative approach is to employ a test statistic that relies on haplotype
frequency estimates rather than haplotype calls. Besides the consequences of estimates
deviating from their true values, this alternative approach faces complications of its own.
In some situations, the exact distribution of the test statistic under both the null and
alternative hypotheses can be unclear.
Haplotype-based studies are often hindered by the fact that some haplotypes occur
very rarely. The number of possible haplotypes grows exponentially as the number of
component SNP loci increases. Consequently, the number of possible haplotypes is often
quite large, and many of these possible haplotypes are rare or do not appear at all in the
population. Recent studies have found that haplotypes appear in blocks such that there
are several common variants while many other variants do not appear at all or are very
rare (Daly et al. 2001; Patil et al. 2001; Stephens et al. 2001a; Subrahmanyan et al. 2001;
Gabriel et al. 2002; International HapMap Consortium 2003; International HapMap
Consortium 2005). As mentioned earlier, several strategies, such as clustering based on
similarity (Hoehe et al. 2000), pooling rare haplotypes (Sham and Curtis 1995; Schaid et
al. 2002; Zhao et al. 2003), and applying haplotype diversity criteria for SNP selection
(Johnson et al. 2001; Jannot et al. 2004)
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(http://www-gene.cimr.cam.ac.uk/clayton/software/stata/htSNP/htsnp.pdf),

have

been

utilized to reduce the number of haplotype categories and potentially to gain power.
However, rare or non-existent haplotypes can have other effects on an analysis besides a
reduction in power.
Since multilocus genotypes lack phase information, the testing situation for
haplotype-based association studies is more complex than that for other genetic
association studies where the variants under investigation are directly observed. In tests
of haplotype-based association where haplotype frequencies are estimated from
multilocus genotypes, estimation procedures may find a small frequency for some
haplotypic variants.

There is uncertainty whether haplotypes with small frequency

estimates are present but rare in the sample or not present in the sample at all but merely
compatible with the multilocus genotypes observed. The effect of this situation on the
distribution of the resulting test statistic under both null and alternative hypotheses
remains unclear.

One still expects that the test statistic will follow a central χ2

distribution under H0 and a noncentral χ2 distribution under H1. However, the degrees of
freedom associated with either χ2 distribution are no longer well defined.
In this work, we investigate the distribution of a test statistic which relies on
haplotype frequency estimates to detect an association between a haplotype and disease
status. In particular, we are interested in the distribution of this statistic when some
haplotypic variants are extremely rare or nonexistent. Furthermore, we apply a rule to
predict the distribution of the statistic and evaluate the accuracy of its prediction.
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4.2

Methods
Test statistic. We considered a likelihood ratio statistic for detecting haplotype-

based association with disease. The null hypothesis we test is H 0 : h0 j = h1 j = h* j for all
haplotypes j while the alternative hypothesis is H 1 : h0 j ≠ h1 j for at least one j where
h0 j , h1 j , and h∗ j are the haplotype frequencies for cases, controls, and the entire

population, respectively, for the jth haplotype.

The statistic is computed using the

equation
 LH 
LRT = 2 × ln  1 
 LH 0 

(4.1)

where LH1 and LH 0 are the likelihood of the data under the alternative and null
hypotheses, respectively. Each likelihood (L) can be expressed as
N 

L = ∏  ∑ hi1 hi2 


i =1  (i1 ,i2 )∈H i


(4.2)

where N is the number of individuals genotyped, Hi is the set of haplotype pairs
compatible with the ith multilocus genotype, and hi1 and hi2 are haplotype frequencies for
a haplotype pair consistent with the ith multilocus genotype. Expressing these likelihoods
in terms of the haplotype frequencies (equation (4.2)), we have a missing data problem
(since we do not observe phase directly). However, we can overcome this hurdle by
applying the EM algorithm (Dempster et al. 1977) to find these likelihoods and estimates
of the haplotype frequencies. We implement this strategy by employing the software
package EHP (see Electronic Resource Information). This software was developed to
compute haplotype frequency estimates for datasets where the DNA samples from
several individuals have been pooled together. However, since our analysis did not
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require any pooling of samples, we set our pool size to one. Equation (4.1) can be
rewritten as:
LRT = 2 × [ln[L0 ] + ln[L1 ] − ln[L∗ ]]

(4.3)

where L0 , L1 , and L∗ are the likelihoods computed from the multilocus genotypes from
cases alone, controls alone, and all samples, respectively. The reader should note that L∗
represents the likelihood under H0 since the haplotype frequencies must be equal for
cases and controls. In addition, the product of L0 and L1 represents the likelihood under
H1 since the haplotype frequencies for cases and controls are unconstrained. Applying
the EM algorithm (Dempster et al. 1977) as implemented in EHP, we computed L0 , L1 ,
and L∗ and utilized equation (4.3) to find the LRT statistic. To differentiate this LRT
statistic from LRTae and LRTstd described in the previous chapter, we will refer to it as
LRTem from this point forward.

Description of data generation and analysis. To investigate the distribution of

the LRT statistic for a variety of situations, we applied LRTem to many simulated datasets.
Figure 4.1 illustrates the procedure we used to simulate the data and compute the LRTem
statistic under the null and alternative hypotheses.

For each replicate dataset, we

simulated haplotype pairs for each individual from known frequencies (population
haplotype frequencies under H0 and conditional haplotype frequencies under H1). Next
we removed the phase information for each individual.

We utilized the remaining

multilocus genotypes to compute the LRTem statistic using the EHP software as described
above. After all replicate datasets had been simulated, we examined the distribution of
the resulting LRTem statistics. In order to find the distribution from which the LRTem
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statistics derive, we performed a goodness-of-fit test, the Kolmogorov-Smirnov (KS) test,
for χ2 distributions with various degrees of freedom. Since all KS tests in this chapter are
for χ2 distributions, we use the notation KSv, j to indicate a KS test for a χ2 distribution
with noncentral parameter, v, and degrees of freedom, j.

In addition, we visually

compared distributional plots of the LRTem statistic with several χ2 distributions with
various degrees of freedom.
Figure 4.1 Schematic flow chart illustrating the procedure for data simulation and

analysis
A)

Simulate haplotypes from known population frequencies
and arbitrarily assign to cases and controls.

B)

Simulate haplotypes from known frequencies
(conditional on affection status). These conditional
frequencies are based on the selected disease model.

Create
many
replicate
datasets.
Find the
LRTem
statistic

Remove phase
leaving only
multilocus
genotypes
for each
individual.

Use EM algorithm (as implemented
in the EHP software) to calculate
the likelihood and estimate
haplotype frequencies from the
multilocus genotypes for cases
separately, controls separately,
and all individuals pooled

Examine the distribution of the LRT statistics after all replicates completed
and compare with c2 distributions with various degrees of freedom

Legend for Figure 4.1: This schematic flow chart illustrates the procedure employed to create a
distribution of LRTem statistics under (A) the null hypothesis and (B) the alternative hypothesis by
way of data simulation.
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Two SNP scenario
Examination of the distributional properties of LRTem under the null
hypothesis. As in chapter 3, for the simplest non-trivial case, the scenario where the

haplotype under evaluation includes two SNPs, we applied a factorial design (Box et al.
1978). Here we utilized the factorial design to perform a comprehensive study of the
distributional properties of LRTem. Table 4.1 contains the factorial design settings for the
scenario involving two SNP markers. We consider a 2 g factorial design, where g = 4.
We reduced the number of experimental runs from 16 to 12 due to redundancy. For
example, a run with a haplotype comprised of a SNP with minor allele frequency 0.5 at
the locus 1 and a SNP with minor allele frequency 0.01 at locus 2 is equivalent to a run
with a haplotype comprised of a SNP with minor allele frequency 0.01 at locus 1 and a
SNP with minor allele frequency 0.5 at locus 2 (with all other factors having equal
settings to those for the first run). Since minor allele frequencies of 0.05 and 0.01 are
commonly used thresholds for SNP selection in association studies, we chose 0.01 (the
more extreme threshold) as the low setting for the minor allele frequency at loci 1 and 2.
Within each replicate dataset, the number of cases and controls were equal. During each
run, 10,000 replicate datasets were simulated.
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Table 4.1 Factorial design parameter settings assuming the haplotype under

investigation contains two SNP markers
Description of parameter

Low

High

Number of subjects (equal cases and controls)
Minor allele frequency at locus 1 (MAF1)
Minor allele frequency at locus 2 (MAF2)
LD between locus 1 and 2 (measured by D’)

500
0.01
0.01
0

2000
0.5
0.5
0.9

Legend for Table 4.1: This table presents the settings for all parameters considered in the
simulations to study the distribution of LRTem under H0 and H1 assuming the haplotype under
investigation contains two SNP markers. We consider a 2 g factorial design, where g = 4. The
number of experimental runs was reduced from 16 to 12 due to redundancy.

D’ is the

standardized linkage disequilibrium measure. The simulations included 10,000 replicates, and
EHP was used to estimate haplotype frequencies and calculate likelihoods for LRTem.

Examination of the distributional properties of LRTem under the alternative
hypothesis.

We also examined the distribution of the LRTem statistics under the

hypothesis that a disease allele at an unobserved locus exists in linkage disequilibrium
(LD) with the haplotype under study. Table 4.1 contains the factorial design settings for
the study of the distribution of LRTem under H1. As for the study under H0, the allele
frequencies at each marker locus and the LD between marker loci were used to determine
the population haplotype frequencies.

For the study under H0, these haplotype

frequencies were used directly to simulate haplotypes. However, for the study under H1,
we used the population haplotype frequencies to compute the conditional (on case status)
haplotype frequencies. These conditional haplotype frequencies were then used, in turn,
to simulate haplotypes for case and control individuals.

Conditional haplotype

frequencies were found from population haplotype frequencies and specified disease
model parameters by a method described by Sham and subsequently by De La Vega et al.
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(Sham 1998; De La Vega et al. 2005) (also see the Power for Association with Error
(PAWE) website at http://linkage.rockefeller.edu/derek/pawe1.html).

However, we

selected a specific haplotype to be in LD with the disease allele. For completeness,
details regarding the conditional haplotype frequencies including notation and
computation as described by De La Vega et al. (2005) are provided in subsection 3.2 of
chapter 3. For all runs under H1, the generating haplotype frequencies for cases and
controls were based on a dominant disease model ( R2 = R1 ) with f = 0.025, R2 = 3.5, and
DAF = 0.07. In addition, the marker haplotype with a frequency closest to 0.05 was

placed in LD (D’ = 0.9) with the disease allele. (In the previous chapter, we utilized
these disease parameter settings for the in-depth power analysis for both the two SNP and
multi-SNP scenarios.) Subsection 3.2 also provides an example of how the conditional
As for the study under H0, we reduced the number of

frequencies are computed.

experimental runs from 16 to 12 due to redundancy. Again, the number of cases and
controls were equal within each replicate dataset, and 10,000 replicate datasets were
simulated during each run.

Multi-SNP scenario
Examination of the distributional properties of LRTem under the null and
alternative hypotheses.

We performed additional simulations to investigate the

distributional properties of LRTem when applied to haplotypes comprised of larger
numbers of SNPs. Table 4.2 contains the factorial design settings for the study of the
distribution of LRTem under H0 and H1 when the haplotype under investigation contains
many SNPs. Our simulations were based on haplotype frequencies from two datasets—
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the Horan (Horan et al. 2003) and HapMap TAP2 (International HapMap Consortium
2003; International HapMap Consortium 2005) datasets. The datasets are described in
subsection 3.2 of chapter 3 along with an explanation of how the generating population
haplotype frequencies were attained from each dataset. Also in subsection 3.2, Figure 3.2
displays the inter-marker LD present in each dataset. For the experimental runs (both
under H0 and H1) based on these datasets, we simulated haplotypes comprised of five and
ten SNPs. In Figure 3.2, the five SNP markers comprising the five-SNP haplotype are
indicated with an asterisk (*) for both Horan and HAPMAP TAP2 datasets. For the
experimental runs with the ten-SNP haplotype, we used the last ten SNP markers
appearing in Figure 3.2A for the Horan dataset, and all ten SNP markers appearing in
Figure 3.2B for the HAPMAP TAP2 dataset. The number of cases and controls were
equal within each replicate dataset, and 1000 replicate datasets were simulated during
each run.
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Table 4.2 Factorial design parameter settings assuming the haplotype under

investigation contains many SNP markers
Description of parameter

Low

Inter-marker LD
HAPMAP TAP2
Number of SNPs comprising haplotype
5
Number of subjects (equal cases and controls)
500

High
Horan
10
2000

Legend for Table 4.2: This table presents the settings for all parameters considered in the
simulations to study the distribution of LRTem under H0 and H1 assuming the haplotype under
investigation contains many (more than two) SNP markers. We consider a 2 g factorial design,
where g = 3. Simulations were based on population haplotype frequencies from a dataset with
low inter-marker LD, the Horan dataset (Horan et al. 2003), and on population haplotype
frequencies from a dataset with high inter-marker LD, the HAPMAP TAP2 dataset (International
HapMap Consortium 2003; International HapMap Consortium 2005). The simulations included
1000 replicates, and EHP was used to estimate haplotype frequencies and calculate likelihoods
for LRTem.

Predicting the degrees of freedom. One goal of this work is to establish a “rule

of thumb” for predicting the degrees of freedom for the χ2 distribution which most
closely resembles the distribution of LRTem for a set of simulation parameters. The rule
that we test is that
J

J

J

j =1

j =1

j =1

df = ∑ x0 j + ∑ x1 j − ∑ x∗ j − 1

(4.4)

where
1 if ĥ∗ j ≥ 1 2t
1 if ĥ0 j ≥ 1 2t 0
1 if ĥ1 j ≥ 1 2t1
, x0 j = 
, and x1 j = 
.
x∗ j = 
0 if ĥ∗ j < 1 2t
0 if ĥ0 j < 1 2t 0
0 if ĥ1 j < 1 2t1

In equation (4.4), df is the predicted number of degrees of freedom for the χ2 distribution;
J is the total number of possible haplotypes; ĥ0 j , ĥ1 j , and ĥ∗ j are frequency estimates for
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the jth haplotype using cases alone, controls alone, and all samples, respectively; and t 0 ,
t1 , and t are the number of cases, the number of controls, and the total number of

samples, respectively.
According to statistical theory, for large sample sizes the LRTem statistic
asymptotically follows a central χ2 distribution under H0 and a noncentral χ2 distribution
under H1 (Mitra 1958; Hogg and Craig 1995; Agresti 1996). The number of degrees of
freedom associated with either χ2 distribution equals the difference between the number
of free parameters estimated under H1 and H0 in equation (4.1). For LRTem in the context
of haplotype-based association, this quantity can be expressed as
df = η 0 + η1 − η* − 1

(4.5)

where η 0 , η1 , and η∗ are the number of haplotypes estimated using cases alone, controls
alone, and all samples, respectively. The rule described above in equation (4.4) examines
how η 0 , η1 , and η∗ should be found. Suppose we estimate haplotype frequencies from
multilocus genotypes from t individuals. A single individual possessing one copy of the
variant represents the minimum frequency of a haplotypic variant present in this sample.
Thus, the rule described in equation (4.4) applies this minimum frequency ( 1 2t ) as a
threshold to distinguish haplotypes present in the sample from those that are not present.
To test the performance of this rule, we computed the average values for x∗ j , x0 j ,
and x1 j over all replicate datasets for cases alone, controls alone, and all samples together
and computed the predicted degrees of freedom using equation (4.4). We rounded the
value computed for df and plotted the χ2 distribution with df degrees of freedom (along
with χ2 distributions with df –1 and df +1) for comparison with the distribution LRTem.
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The software package R (see Electronic Resource Information) was used to create these
plots.

The noncentrality parameter (ncp) for the “predicted” χ2 distribution was

computed using
J

ncp = 2 × t1 ∑
j =1

(h

− h1 j )

2

0j



t
 h0 j + 1 h1 j 
t0



(4.6)

as described by others (see http://linkage.rockefeller.edu/derek/pawe2.html) (Mitra 1958;
Sham 1998; Gordon et al. 2002). Under the null hypothesis, ncp = 0 since h0 j and h1 j
are equal for each haplotype j.

4.3

Results
At the end of section 4.3, Table 4.3 summarizes the results for all experimental

runs (both two SNP and multi-SNP scenarios under H0 and H1) presented in this chapter.

Two SNP scenario.
Examination of the distributional properties of LRTem under the null
hypothesis. Our simulation results under the null hypothesis can be classified into three

categories—1) experimental runs where the rule described in equation (4.4) successfully
predicts the correct distribution; 2) experimental runs where the rule described in
equation (4.4) successfully predicts the correct distribution for larger sample sizes only;
and 3) experimental runs where the rule described in equation (4.4) fails to predict the
correct distribution regardless of sample size. Figure 4.2 displays the distribution of
LRTem for simulation runs that represent each of these categories. In our factorial design
(Table 4.1), some experimental runs contain no rare haplotypes in the generating
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haplotype frequencies. One example is the run in which MAF1 = 0.5, MAF2 = 0.5, and
the LD between locus 1 and 2 (measured by D’) is 0. These parameter settings result in
four haplotypes with equal frequencies (0.25). These frequencies serve as the generating
frequencies for the simulation. Figure 4.2A displays a histogram and density line for the
LRTem statistic computed from simulations utilizing these parameter settings under H0 for
500 samples (equal numbers of cases and controls).

Figure 4.2A shows that the

distribution of LRTem for this experimental run closely resembles a central χ2 distribution
with 3 degrees of freedom, the distribution predicted by the rule in equation (4.4). Since
all the generating haplotype frequencies are large, we expected LRTem for this run to
exhibit this behavior. For this run, the KS0,3 test (testing a central χ2 distribution with
df = 3) p-value = 0.248 indicating that the distribution of LRTem is consistent with a

central χ2 distribution with 3 degrees of freedom. The experimental run with the same
parameter settings and a sample size of 2000 showed similar results (results not shown).
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Figure 4.2 Histograms displaying the distribution of LRTem under H0 for the two SNP

scenario

Legend for Figure 4.2: The histograms display the distribution of LRTem along with the density
lines for several central χ2 distributions for a number of experimental runs. The distribution of
LRTem was created by simulating haplotypes comprised of two SNPs under H0.

For (A),

MAF1 = 0.5 and MAF2 = 0.5; for (B and C), MAF1 = 0.5 and MAF2 = 0.01; and for (D)
MAF1 = 0.01 and MAF2 = 0.01. For all runs displayed, LD between SNP 1 and 2 = 0 (measured
by D’). 10,000 replicate datasets comprised of 500 samples (A and B) and 2000 samples (C and
D) were simulated. The graphs were scaled to the observed data, and density lines off the scale
were truncated.
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Other experimental runs required larger sample sizes for the rule described in
equation (4.4) to predict the correct distribution.

The experimental run in which

MAF1 = 0.5, MAF2 = 0.01, and LD between locus 1 and 2 = 0 (measured by D’) exhibited

this behavior. This run had a minimum generating haplotype frequency (0.005) that was
substantially smaller than the minimum generating haplotype frequency for the run
described above yet still greater than any of the thresholds established by the rule
described in equation (4.4).

Figures 4.2B and 4.2C display histograms for LRTem

computed from simulations utilizing these parameter settings. Figure 4.2B shows the
distribution for simulated datasets containing 500 samples while Figure 4.2C shows the
distribution for simulated datasets containing 2000 samples.

In Figure 4.2B, the

distribution of LRTem does not resemble a central χ2 distribution with 2 degrees of
freedom, the distribution predicted by the rule in equation (4.4) for this run. Instead, it
roughly resembles a central χ2 distribution with 3 degrees of freedom. Figure 4.2C
shows that increasing the sample size leads to a better fit with a central χ2 distribution
with 3 degrees of freedom, the distribution predicted with the increased sample size using
the rule described in equation (4.4). Although the distribution of LRTem visually matches
the density plot for the central χ2 distribution with 3 degrees of freedom in Figure 4.2C,
the KS0,3 p-values for both the 500 and 2000 sample size runs are approximately 0. Thus,
the distribution of LRTem for the 2000 sample run still deviates from a central χ2
distribution with 3 degrees of freedom.
The rule described in equation (4.4) failed to predict the distribution for other
experimental runs regardless of the sample size.

The experimental run in which

MAF1 = 0.01, MAF2 = 0.01, and LD between locus 1 and 2 = 0 (measured by D’) is in
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this category. This run had a minimum generating haplotype frequency (0.0001) that was
below all of the thresholds (for both a sample size of 500 and 2000) established by the
rule described in equation (4.4). Figure 4.2D displays a histogram for LRTem computed
from simulations utilizing these parameter settings. Figure 4.2D shows the distribution
for simulated datasets containing 2000 samples. In Figure 4.2D, the distribution of
LRTem does not resemble a central χ2 distribution with 2 degrees of freedom, the
distribution predicted by the rule in equation (4.4) for this experimental run. Instead, the
distribution of LRTem falls between central χ2 distributions with 2 and 3 degrees of
freedom. The distribution of LRTem utilizing the same parameters for simulating datasets
with 500 samples exhibited near identical behavior (results not shown). Thus, in this
case, increasing the sample size did not increase the accuracy of the prediction rule
described in equation (4.4).

Examination of the distributional properties of LRTem under the alternative
hypothesis.

The prediction rule in equation (4.4) was not as successful for our

simulations under the alternative hypothesis for the two SNP scenario. Although for the
majority of cases the distribution of LRTem did not resemble the distribution selected by
the rule, in some situations increasing the sample size provided a distribution of LRTem
predicted by the rule (as we observed under H0). Figures 4.3A and 4.3B display the
distribution of LRTem for one such set of experimental runs.

Here MAF1 = 0.5,

MAF2 = 0.5, and LD between SNP 1 and 2 = 0.9 (measured by D’). Figures 4.3A and

4.3B show the results from simulations of datasets with 500 and 2000 samples,
respectively. Although the distribution of LRTem appears to follow a noncentral χ2
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distribution with df = 3 (the distribution predicted for both runs) in Figure 4.3A, the fit is
improved in Figure 4.3B. Furthermore, only the KS test results for the run with a sample
size of 2000 support the idea that LRTem follows the predicted distribution (KS34.0,3 test
p-value = 0.145 and KS8.5,3 test p-value = 0).

Figures 4.3C and 4.3D display the

distribution of LRTem for datasets of 500 and 2000 samples, respectively, simulated for
haplotypes comprised of two SNPs where MAF1 = 0.01, MAF2 = 0.01, and LD between
SNP 1 and 2 = 0 (measured by D’). The predicted distribution for both experimental runs
is a noncentral χ2 distribution with df = 2; however, the distribution of LRTem in Figures
4.3C and 4.3D seems to bear a greater resemblance to a noncentral χ2 distribution with
df = 3. For the run with 2000 samples, the results of the KS test support the idea that

LRTem follows a noncentral χ2 distribution with df = 3 (KS13.1,3 test p-value = 0.286 and
KS13.1,2 test p-value = 0).
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Figure 4.3 Histograms displaying the distribution of LRTem under H1 for the two SNP

scenario

Legend for Figure 4.3: The histograms display the distribution of LRTem computed from
simulated datasets comprised of 500 samples (A and C) and 2000 samples (B and D) along with
the density lines for several noncentral χ2 distributions. The distribution of LRTem was created by
simulating haplotypes comprised of two SNPs under H1.

For (A) and (B), MAF1 = 0.5,

MAF2 = 0.5, and LD between SNP 1 and 2 = 0.9 (measured by D’) while for (C) and (D),
MAF1 = 0.01, MAF2 = 0.01, and LD between SNP 1 and 2 = 0 (measured by D’).

10,000

replicate datasets containing equal numbers of cases and controls were simulated. The graphs
were scaled to the observed data, and density lines off the scale were truncated.
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Multi-SNP scenario
Examination of the distributional properties of LRTem under the null and
alternative hypotheses. For our simulations under the null and alternative hypotheses

that rely on haplotype frequencies from the Horan dataset, LRTem did not follow the
distribution predicted by equation (4.4).

Figure 4.4 displays histograms for LRTem

computed from simulations utilizing haplotype frequencies from the Horan dataset as the
generating haplotype frequencies. Figures 4.4A and 4.4C show the distribution of LRTem
for a haplotype comprised of 5 SNP markers (for data simulated under H0 and H1,
respectively) while Figures 4.4B and 4.4D show the distribution of LRTem for a
haplotype comprised of 10 SNP markers (for data simulated under H0 and H1,
respectively). The simulations providing the data for Figures 4.4 created 1000 replicate
datasets, each containing 2000 samples (equal numbers of cases and controls). For the
haplotype simulations under H0 or H1 involving 5 SNP markers, the distribution predicted
by equation (4.4) is a central or noncentral (ncp = 64.6), respectively, χ2 distribution with
4 degrees of freedom. Figures 4.4A and 4.4C demonstrate that the distribution of LRTem
more closely approximates a central χ2 distribution with 5 degrees of freedom. The KS0,5
test (under H0) p-value of 0.099 and the KS64.6,5 test (under H1) p-value of 0.163 confirm
this similarity (while the KS0,4 and KS64.6,4 had p-values of 0). When the number of SNPs
included in the haplotype is increased to ten for simulations under H0 or H1, the
distribution predicted by equation (4.4) is a central or noncentral (ncp = 85.3),
respectively, χ2 distribution with 19 degrees of freedom. Figures 4.4B (under H0) and
4.4D (under H1) show that the distribution of LRTem more closely approximates a central
χ2 distribution with 20 degrees of freedom and a noncentral χ2 distribution with 18
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degrees of freedom, respectively. The results from the KS tests indicate that there is the
most evidence to support the idea that, under H0, LRTem is distributed as a central χ2
distribution with 21 degrees of freedom (KS0,21 p-value = 0.054) and, under H1, LRTem is
distributed as a noncentral χ2 distribution with 18 degrees of freedom (KS85.3,18
p-value = 0.342). However, under H1, a noncentral χ2 distribution with 19 degrees of

freedom is also consistent with the data (KS85.3,19 p-value = 0.243).
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Figure 4.4 Histograms displaying the distribution of LRTem for simulations based on

haplotype frequencies from the Horan dataset

Legend for Figure 4.4: The histograms display the distribution of LRTem computed from
simulations based on haplotype frequencies from the Horan dataset along with the density lines
for several central χ2 distributions.

The distribution of LRTem was created by simulating

haplotypes comprised of (A) 5 SNP markers and (B) 10 SNP markers under H0 and haplotypes
comprised of (C) 5 SNP markers and (D) 10 SNP markers under H1. 1000 replicate datasets
containing 2000 samples (equal numbers of cases and controls) were simulated. The graphs were
scaled to the observed data, and density lines off the scale were truncated.
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The rule described by equation (4.4) had some success in determining the
distribution of LRTem for the simulations under H0 and H1 based on haplotype
frequencies from the HAPMAP TAP2 dataset.

Figures 4.5A and 4.5C show the

distribution under H0 and H1, respectively, for a haplotype comprised of 5 SNP markers
while Figures 4.5B and 4.5D show the distribution under H0 and H1, respectively, for a
haplotype comprised of 10 SNP markers.

The simulations providing the data for

Figures 4.5A and 4.5C created 1000 replicate datasets with 2000 samples (equal numbers
of cases and controls) while the simulations providing the data for Figures 4.5B and 4.5D
created 1000 replicate datasets with 500 samples (equal numbers of cases and controls).
For the haplotype simulations involving 5 SNP markers, the distribution predicted by
equation (4.4) under H0 or H1 is a central or noncentral (ncp = 76.3), respectively, χ2
distribution with 9 degrees of freedom. In Figure 4.5A, the distribution of LRTem under
H0 falls between central χ2 distributions with 9 and 10 degrees of freedom. Although the
p-values for the KS tests are small, they favor a central χ2 distribution with 9 degrees of

freedom (KS0,9 p-value = 0.006).

The distribution of LRTem under H1 presented in

Figure 4.5C does not resemble the predicted noncentral χ2 distribution but instead
appears to be derived from a noncentral χ2 distribution with many fewer degrees of
freedom. When we increased the number of SNPs to ten, both under H0 and H1 equation
(4.4) predicted that LRTem would follow a central χ2 distribution with 16 degrees of
freedom. According to Figures 4.5B and 4.5D, the distribution of LRTem falls between
central χ2 distributions with 16 and 17 degrees of freedom. The KS test results under H0
indicate that LRTem most likely follows a central χ2 distribution with 17 degrees of
freedom (KS0,17 p-value = 0.750).

(Interestingly, before rounding, equation (4.4)
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predicted df = 16.4.) Figure 4.5D shows that, under H1, LRTem appears to follow a
noncentral χ2 distribution with df = 16 and ncp = 18.0 (KS18.0,16 p-value = 0.628). Thus,
under H0 and H1, equation (4.4) demonstrated an ability to predict the approximate
correct degrees of freedom for the multi-marker haplotypes simulations although it
lacked consistency for exacting precision.
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Figure 4.5 Histograms displaying the distribution of LRTem for simulations based on

haplotype frequencies from the HAPMAP TAP2 dataset

Legend for Figure 4.5: The histograms display the distribution of LRTem computed from
simulations based on haplotype frequencies from the HAPMAP TAP2 dataset along with the
density lines for several central χ2 distributions. The distribution of LRTem was created by
simulating haplotypes comprised of (A) 5 SNP markers and (B) 10 SNP markers under H0 and
haplotypes comprised of (C) 5 SNP markers and (D) 10 SNP markers under H1. 1000 replicate
datasets containing (A and C) 2000 samples and (B and D) 500 samples (equal numbers of cases
and controls) were simulated. The graphs were scaled to the observed data, and density lines off
the scale were truncated.
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Table 4.3 Summary table for the results from all experimental runs presented

Scenario Hypothesis MAF1 MAF2 LD between SNP 1 and SNP 2 (D') Category Code
H0
Two SNP
H1
Scenario Hypothesis

0.5

0.5

0.0

1

0.5
0.01
0.5
0.01

0.01
0.01
0.5
0.01

0.0
0.0
0.9
0.0

2
3
2
3

Number of SNPs in Haplotype

Category Code

5
10
5
10
5
10
5
10

3
3
3
3
3
3
3
1

Dataset

H0
Horan
H1
Multi-SNP
H0
H1

HAPMAP
TAP2

Legend for Table 4.3: This table summarizes the results for all experimental runs presented in
section 4.3. The category codes are defined as: 1) experimental runs where the rule described in
equation (4.4) successfully predicts the correct distribution; 2) experimental runs where the rule
described in equation (4.4) successfully predicts the correct distribution for larger sample sizes
only; and 3) experimental runs where the rule described in equation (4.4) fails to predict the
correct distribution regardless of sample size.

4.4

Discussion
Even for the multi-SNP scenario where the range for the possible degrees of

freedom of the χ2 distribution is much wider (from 1 to 2b, where b is the number of
SNPs comprising the haplotype), the rule described in equation (4.4) was fairly consistent
in predicting the χ2 distribution closest to the distribution of LRTem within a few degrees
of freedom. However, while the rule sometimes predicted the correct distribution of the
test statistic, it was not consistently accurate. Because of this inconsistency, we advocate
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applying permutation and simulation methods to empirically generate the distribution of
the test statistic under the null and alternative hypotheses, respectively, rather than
applying the rule in equation (4.4). Future research is required to investigate alternative
threshold settings and refine the prediction capability of this rule.
Knowing the precise distribution of a test statistic under the null and alternative
hypotheses can be extremely practical. This knowledge allows researchers the freedom
to employ the distribution to determine the statistical significance (distribution under H0)
and power (distribution under H1) of the test rather than relying on more computationally
intensive methods such as permutation and simulation to generate the null and alternative
distributions empirically. Of course, reliance on a classically defined distribution (e.g.
normal distribution, central χ2 distribution, F distribution, etc.) that does not accurately
describe the distribution of a statistic under the null and alternative hypotheses can lead to
erroneous estimates of the type I error and power. In such cases, empirical techniques
such as permutation and simulation are necessary even at the expense of computational
resources. Often, this compromise is inconsequential when analyzing a real dataset. In
fact, with modern computer processors and efficiently written code thousands of
permutations can generally be performed in a reasonable timeframe. The limitation of
this approach is often only apparent when many tests, all requiring a separate permutation
procedure, are performed. Obviously, this situation arises for genome scans but can also
be present for a haplotype-based association study that employs a sliding window
approach across the SNPs in a single candidate gene.
Estimating low haplotype frequency estimates while computing LRTem is
somewhat analogous to constructing a sparse contingency table. However, methods that
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utilize observations from a contingency table exhibit two qualities not available to
likelihood-based methods that rely on haplotype frequency estimates – 1) a clear
guideline defining when the central χ2 distribution can be applied to determine the
statistical significance and 2) the ability to combine categories containing rare
observations. Unless Cochran’s rule is violated (five or more observations in each cell of
the contingency table), the central χ2 distribution can be applied to determine the
statistical significance for Pearson χ2 or likelihood ratio statistics that utilize a
contingency table (Cochran 1952). We have been unable to establish a parallel guideline
for likelihood-based statistics that rely directly on haplotype frequency estimates. In
addition, rare observations can be pooled (Sham and Curtis 1995; Schaid et al. 2002;
Zhao et al. 2003) to produce a contingency table that is no longer sparse and contains a
reduced number of categories. While frequency estimates for rare haplotypes can be
pooled, for LRTem the EM algorithm computes the likelihood during the haplotype
frequency estimation step. Thus, pooling does not affect the computation of the statistic.
The likelihood could be computed in a subsequent step using the multinomial distribution
after haplotype frequencies were estimated and low haplotype frequency estimates were
pooled. However, this approach is contrary to a key feature of LRTem in that it treats
expected counts from the estimates as observations rather than working directly with
estimates. By working directly with haplotype frequency estimates in the expression for
the likelihood, LRTem avoids assumptions regarding the “observed” counts required for a
contingency table.
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CHAPTER 5: DISCUSSION

5.1

Synopsis
Although haplotypes can provide a powerful tool for gene mapping (Martin et al.

2000; Akey et al. 2001; Fallin et al. 2001; Morris and Kaplan 2002; Zaykin et al. 2002;
Botstein and Risch 2003; Clark 2004), several factors add to the complexity of haplotypebased association studies relative to other forms of genetic association. First, in common
practice, original observations are multilocus genotypes, which lack phase information.
Consequently, estimation or inference procedures are required to apply a haplotype-based
test. Second, haplotypes are a combination of alleles at multiple loci generally resulting
in a large number of haplotypic variants. In the context of association studies, a large
number of variants corresponds to many degrees of freedom and often a less powerful
test. Third, as the number of marker loci comprising a haplotype grows, the number of
possible haplotypic variants increases exponentially; however, many of these variants are
not present in the population even though they may have positive frequency estimates.
The complexity caused by these factors surfaces in several issues uniquely present in
haplotype-base studies of association (as compared with other genetic association tests).
For this thesis, we have developed work aimed at addressing several of these issues
inherent in tests of haplotype-based association. Specifically, these issues include 1) the
multiple testing problem introduced by employing hierarchical clustering to group similar
haplotypes; 2) haplotype misclassification resulting from statistically inferring haplotype
pairs from multilocus genotypes; and 3) uncertainty predicting the precise distribution of
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the haplotype-based association test statistic when haplotype frequency estimates are very
small or zero.
In the first part of this thesis, we examined the practice of applying a hierarchical
clustering to haplotypes and then performing statistical tests at each step in the resulting
hierarchy in the framework of multiple testing. To determine the empirical significance
level or global p-value of the experiment, we proposed a method that takes into account
the clustering process as well as the correlation structure of the tests performed. We
applied our approach to datasets from haplotype association and microarray expression
studies where hierarchical clustering has been used. In all of the cases we examined, we
found that relying on one set of classes in the course of clustering leads to significance
levels that are too small when compared with the significance level associated with an
overall statistic that incorporates the process of clustering. In other words, relying on one
step of clustering may furnish a formally significant result while the overall experiment is
not significant.
In the second portion of this work, our simulations showed that the
misclassification present in calling phased haplotypes from multilocus genotypes using
statistical methods is complete. That is, each misclassified haplotype pair is consistently
misclassified as the same incorrect haplotype pair throughout the entire dataset. In
addition, our simulations under the null hypothesis of no association demonstrate that
applying the central χ2 distribution to evaluate the significance of test statistics produces
conservative and anticonservative p-values while applying permutation methods
consistently produces p-values that maintain the nominal false positive rate.
Consequently, permutation methods should be exclusively used to determine statistical
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significance for the tests we perform. As expected, the LRTae provides the greatest
advantage in terms of power over the LRTstd in situations where more haplotype
misclassification errors are present. These situations arise when the haplotype under
investigation is comprised of many SNP markers with low pair-wise intermarker LD.
For fixed costs, the power gain of the LRTae over the LRTstd varied depending on
the relative costs of genotyping, molecular haplotyping, and phenotyping. In general, the
LRTae showed the greatest benefit over the LRTstd when the cost of phenotyping was very
high relative to the cost of genotyping. This situation is likely to occur in a candidate
gene replication study as opposed to a genome-wide association study. For intermediate
phenotyping to genotyping cost ratios (e.g. C p / C g = 25 ), the LRTae may still provide a
power advantage if the cost ratio of molecular haplotyping to genotyping is low
( C mh / C g < 10 for α ≥ 0.5 ).

Currently, inexpensive long-range PCR methods for

molecular haplotyping are under development. As technology improves leading to less
expensive molecular haplotyping methods, the LRTae will become applicable to a wider
set of circumstances.
The final part of this thesis proposes a rule for predicting the distribution of a
likelihood-based statistic that relies on haplotype frequency estimates.

The rule

consistently predicted the χ2 distribution closest to the distribution of the statistic within a
few degrees of freedom even for haplotypes containing many SNP markers. However,
the rule did not consistently predict the distribution of the test statistic with pinpoint
accuracy. Because of this inconsistent performance, we do not advocate applying the
predicted distribution to determine statistical significance or power. Instead, permutation
and simulation techniques should be employed to generate the distribution of the statistic
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under the null hypothesis for determination of type I error and under the alternative
hypotheses for determination of power, respectively.

5.2

Future Directions
This thesis introduces unique approaches for researchers utilizing haplotypes in

case-control study designs to localize disease genes. The approaches proposed overcome
pitfalls in analyzing datasets; however, they also have several limitations. One such
limitation that is relevant for all three strategies described above is the means for
computing type I error. In each case, permutation proves to be the most reliable method
because of the possibility of sparse datasets. However, there are computational costs for
this reliability. With modern processor speeds, analyses which utilize a large number of
permutations can be performed in a practical amount of time. However, in the case of
our computation of the global p-values for datasets where hierarchical clustering has been
applied, the procedure is computationally more intensive. After permuting the data to
compute null statistics, the procedure requires a myriad of comparisons between these
null statistics (at the same step in the hierarchy) to compute null p-values. As a result,
this procedure can be time-consuming, especially if the hierarchy created by clustering
contains many steps. Similarly, the computational time required for permutation can be a
factor when many association tests are performed at different locations in the genome, as
is the case for a genome-wide scan. In addition, this situation arises for haplotype-based
association studies within a single candidate gene that use a sliding window across the
SNP markers in the gene. Permutation can be a valuable tool; however, the researcher
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needs to be aware of the context of the application to plan for the time required for the
procedure.
Aside from the computational issues, some limitations are inherent in the
statistical methods themselves. For example, the LRTae procedure relies on haplotype
pairs to detect association. As stated above, the number of haplotypes present can be
quite large. Consequently, the number of inferred haplotype pairs can be very large
( 2!(ww−! 2 )! , where w is the number of inferred haplotypes) resulting in many degrees of
freedom for this test. Tests with larger degrees of freedom are generally equated with a
loss in power. Thus, methods which examine single haplotypes (Schaid et al. 2002;
Zaykin et al. 2002; Stram et al. 2003) rather than haplotype pairs may be more powerful
than LRTae. Future research will need to compare the power for these approaches with
that of the LRTae. Another option is to develop a version of the Cochran-Armitage
Linear Test of Trend (Cochran 1954; Armitage 1955; Czika and Weir 2004) which
incorporates a double-sampling procedure to correct for haplotype miscalls. Unlike the
LRTae which makes no assumptions regarding a disease model, the Cochran-Armitage
Linear Test of Trend relies on specific weights for each risk category and has only one
degree of freedom. As a result, this test has the potential to be very powerful relative to
other haplotype-based association tests, especially with the added capability of allowing
for haplotype misclassification. However, specifying the incorrect disease model can
negatively impact the power of the test (Freidlin et al. 2002). Future research will need to
develop this test and assess its robustness to incorrect model selection.
Another potential limitation of LRTae is that the method assumes non-differential
misclassification between cases and controls in estimating haplotype misclassification
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rates. However, this assumption is not necessarily valid. A future research direction is to
extend LRTae to estimate haplotype misclassification rates separately from cases and
controls. Presumably, this feature will increase the effectiveness of the test.
In our power studies of LRTae and LRTstd, we used the entire dataset to infer
haplotype pairs for each individual. We chose this approach because 1) it is conservative
in terms of the power analysis (since differences between haplotype pair frequencies in
cases and controls should not be as great); 2) the EM algorithm shows improved accuracy
for haplotype frequency estimates when larger sample sizes are used (Fallin and Schork
2000); and 3) the EM algorithm assumes Hardy-Weinberg equilibrium, and one is more
likely to violate this assumption when analyzing cases and controls separately. However,
in practice researchers are more likely to examine cases and controls separately while
inferring haplotype pairs. Presumably, the power will increase for both LRTae and LRTstd
for an analysis conducted in this fashion; however, the relative power gain is not clear.
Additional studies are required to assess the power of LRTae relative to LRTstd for data
analyzed with this alternative inference scheme.
Finally, our rule for determining the distribution of LRTem did not consistently
provide a precisely accurate prediction. In some cases, a larger sample size improved the
rule’s accuracy. There are a number of possible explanations for this improvement.
First, an increased sample size reduces the sparseness of the dataset.

Second, an

increased sample size improves the accuracy of the haplotype frequency estimates.
Third, an increased sample size decreases the frequency threshold for distinguishing
haplotypes present in the sample from those that are not present. Future research is
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required to refine the prediction rule by investigating alternative algorithms for
determining the thresholds for the estimated haplotype frequencies.
Technological advancements, in the form of SNP chips and online databases,
have provided the capability to cost-effectively assay and manage hundreds of thousands
of SNP markers throughout the genome (Smith 2005). With this explosion of genetic
data, haplotype-based association studies have tremendous potential to localize disease
genes. Specifically, genotypes are available genome-wide with an average density less
than a kilobase. Prior to SNP chip technology which allows for this great density of
genetic information, genome-scans were performed at substantially lower densities, such
that the markers were in linkage equilibrium with one another and haplotype-based
association analyses were less meaningful. Now the desire for molecular haplotypes
presents a new technological frontier.

Currently, the perception among molecular

biologists appears to be that molecular haplotyping is too expensive to warrant
widespread use. However, the cost of molecular haplotypes over small regions of the
genome can be roughly equivalent to that for performing fluorescent polymerase chain
reactions (Proudnikov et al. 2004; Proudnikov et al. 2006). In addition, industry has
shown a serious interest in developing resources to reduce the cost of longer-range
molecular haplotypes (Smith 2005). As molecular haplotyping becomes more affordable
and hence more commonly used, the approaches explained in this thesis will continue to
be relevant for identifying genes for complex traits.
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NOTATION INDEX

Expression

Brief Description

Cg

cost of genotyping

C mh

cost of molecular haplotyping

Cp

cost of phenotyping

C p Cg

cost ratio of phenotyping to genotyping

df

degrees of freedom for the (central or noncentral) χ2 distribution

D’

standardized LD parameter, ( 0 ≤ D' ≤ 1)

Dmax

maximum possible LD

DAF

disease allele frequency

fi

penetrance associated with possessing i copies of the disease allele

g

number of variables in a (fractional) factorial design

hj or h∗ j

population haplotype frequency of the jth haplotype (consisting of
exclusively of marker loci)

h0 j

haplotype frequency in cases of the jth haplotype

h1 j

haplotype frequency in controls of the jth haplotype

h+,j

frequency of disease-marker haplotype containing the wild-type
allele (+) at the disease locus and the marker haplotype j

hd,j

frequency of disease-marker haplotype containing the disease
allele (d) at the disease locus and the marker haplotype j

hi1 and hi2

pair of haplotype frequencies for a haplotype pair consistent with
the ith multilocus genotype

ĥ∗ j

frequency estimates using all samples for the jth haplotype

ĥ0 j

frequency estimates using cases alone for the jth haplotype

ĥ1 j

frequency estimates using controls alone for the jth haplotype

Hi

set of haplotype pairs compatible with the ith multilocus genotype
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I i , j1 , j2

conditional (on case status i) haplotype pair frequency for
haplotype pair j1, j2

I i , j3

conditional (on case status i) haplotype frequency for haplotype j3

J

number of total possible haplotypes

k

number of haplotype pairs

KSvj

the Kolmogorov-Smirnov (KS) test for a χ2 distribution with
noncentrality parameter (ncp) of v and degrees of freedom (df) of j

ln( L1, ae )

log-likelihood of data, where haplotype pair frequencies pit' j ' are
allowed to differ among different phenotype classes

ln( L0, ae )

log-likelihood of data , where haplotype pair frequencies pit' j ' are
constrained to be equal among different phenotype classes

ln( L1, std )

log-likelihood of data when not correcting for misclassification,
where haplotype pair frequencies pi ' j are allowed to differ among
different phenotype classes

ln( L0, std )

log-likelihood of data when not correcting for misclassification,
where haplotype pair frequencies pi ' j are constrained to be equal
among different phenotype classes

L

likelihood of the data

LH 0

likelihood of the data under the null hypothesis

L H1

likelihood of the data under the alternative hypothesis

L∗

likelihood computed from the multilocus genotypes from cases and
controls together

L0

likelihood computed from the multilocus genotypes from cases
alone

L1

likelihood computed from the multilocus genotypes from controls
alone
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LD(j)

amount of deviation from the equilibrium value for a diseasemarker haplotype comprised of the jth marker haplotype and either
the wild type or disease allele.

LRTstd

standard likelihood ratio statistic (computed from contingency table)

LRTae

likelihood ratio statistic allowing for errors (computed from
contingency table)

m j' j

number of individuals that have been classified by the fallible
method as haplotype pair j and by the infallible method as
haplotype pair j ' , where 1 ≤ j , j ' ≤ k (where k is the number of
haplotype pairs)

m j '+

number of individuals that have been classified by the infallible
method as haplotype pair j ' , where 1 ≤ j ' ≤ k (where k is the
number of haplotype pairs)

m

number of permutations

mini ( pi )

minimum of local p-values

MAFj

minor allele frequency at the jth SNP locus

n

number of steps in hierarchy

ni('1j)' j

number of individuals with (true) phenotype category i ' , true
haplotype pair category j ' , and observed haplotype pair category j

ni('2j)

number of individuals with (true) phenotype category i ' and
observed haplotype pair category j

ncp

noncentrality parameter for the noncentral χ2 distribution

N

sample size for the LRTstd

NDS

sample size for the LRTae

NDS*
r
p = ( p1 , p 2 ,..., p n )

sample size for the LRTae determined from α

pmin

global p-value

pd

allele frequency of disease-causing allele at the disease locus

p+

allele frequency of the wild-type allele at the disease locus

vector of local p-values
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pi ' j

observed population frequency of haplotype pair j for individuals
with true phenotype i '

p it' j '

true population frequency of haplotype pair j ' for individuals with
phenotype i '

p*t j '

true population frequency of haplotype pair j ' under the null
hypothesis that p 0t j ' = p1t j ' = p*t j '

qit'

true sampling frequency of phenotype i '

r = C mh C g

cost ratio of molecular haplotyping to genotyping

R1

genotype relative risk for the heterozygote

R2

genotype relative risk for the homozygote

s

number of genetic variants

t

total number of individuals (used to determine a threshold from
haplotype frequencies)

t0

number of cases (used to determine a threshold from haplotype
frequencies)

t1

number of controls (used to determine threshold from haplotype
frequencies)

u

mean vector

V

variance-covariance matrix

w

number of haplotypes (consisting of exclusively of marker loci)

x∗ j

indicator function for the jth haplotype (associated with frequency
estimates using all samples)

x0 j

indicator function for the jth haplotype (associated with frequency
estimates using only cases)

x1 j

indicator function for the jth haplotype (associated with frequency
estimates using only controls)

r
X = ( X 1 , X 2 ,..., X n )

vector of statistical values (generic)

Xnull

matrix of null statistics
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Xj

event that an individual has observed haplotype pair j ,1 ≤ j ≤ k
(where k is the number of haplotype pairs)

X tj '

event that an individual has true haplotype pair j ' ,1 ≤ j ' ≤ k (where
k is the number of haplotype pairs)

X it' j '

event that an individual has phenotype i ' , (i ' = 0,1) and true
haplotype pair j ' ,1 ≤ j ' ≤ k (where k is the number of haplotype
pairs)

Yi t'

event that an individual has phenotype i ' , (i ' = 0,1)

Yi

multivariate normal random variable transformed from null local
p-value at ith step in hierarchy

α

double-sample proportion

α

mean double-sample proportion

δ

posterior probability threshold for the threshold double-sample
selection method

η∗

number of haplotypes estimated using all samples

η0

number of haplotypes estimated using controls alone

η1

number of haplotypes estimated using cases alone

θ j' j

misclassification probability that the true haplotype pair j ' will be
misclassified as haplotype pair j

φ

disease prevalence
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ELECTRONIC RESOURCE INFORMATION

The adenocarcinoma dataset published by Garber et al. (Garber et al. 2001) can be found
at http://genome-www.stanford.edu/lung_cancer/adeno/index.shtml.
The B-cell lymphoma dataset published by Alizadeh et al. (Alizadeh et al. 2000) can be
found at http://llmpp.nih.gov/lymphoma/.
The documentation for StatXact 5 software can be found at http://www.cytel.com/.
The documentation for SNPHAP and PHASE can be found at
http://www-gene.cimr.cam.ac.uk/clayton/software/ and
http://www.stat.washington.edu/stephens/software.html, respectively.
The documentation for PAWE can be found at
http://linkage.rockefeller.edu/derek/pawe1.html.
Data for the estimation of haplotype frequencies from SNP markers within the TAP2
gene were downloaded from http://www.hapmap.org/downloads/index.html.en
(HapMap public release #16c.1).
LRTae software is available at ftp://linkage.rockefeller.edu/software/lrtae.
EHP software is available at http://linkage.rockefeller.edu/yyang/resources.html.
The documentation for the software package R is available at http://www.r-project.org/.
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